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Thesis Abstract 
 
Background 
Dysfunction of Autonomic Nervous System is a typical feature of chronic heart failure 
and other cardiovascular disease and is associated with severity of the disease and 
prognosis of cardiac patients. As a simple non-invasive technology, heart rate variability 
analysis provides reliable information on autonomic modulation of heart rate, and it has 
been a valuable tool to understand psychopathological mechanisms. A small number of 
studies focused on automatic discrimination between healthy subject and patients 
suffering from congestive heart failure using data-mining methods. However, to the best 
of author’ knowledge no study investigated the assessment of disease severity by using 
Heart Rate Variability analysis and data-mining. Moreover, autonomic nervous system 
disturbance and cardiovascular disorders including carotid sinus hypersensitivity, serious 
arrhythmias, severe valvular heart disease, and coronary heart disease may be 
underestimated causes of falls. To best of author’ knowledge, only one study investigate 
Heart Rate Variability in fallers and non-fallers among a geriatric population.  
The aim of this thesis was to research and develop automatic methods based on 
Autonomous Nervous System assessment for evaluation of risk in cardiac patients. Heart 
Rate Variability analysis has been performed and several data-mining methods have been 
combined to achieve the following goals: automatic assessment of disease severity in 
Congestive Heart Failure patients; automatic identification of hypertensive patients at 
higher risk of developing vascular events, and automatic identification of hypertensive 
patients with a history of falls. 
Materials and methods  
Heart Rate Variability analysis was performed according to the international guidelines 
recommendation and the most recent scientific evidences, particularly for frequency 
domain and non-linear measures. Several features selection and machine learning 
algorithms have been combined to achieve the goals. In particular, in any application, 
methods which provide an intelligible output have been adopted and preferred in order to 
extract relevant information. Finally, cross-validation methods have been adopted and 
improved in order to provide a rigorous model selection and evaluation. When available, 
public datasets are preferred. Otherwise, ad hoc datasets have been developed and they 
are planned to be publicly available so that other investigators could replicate the results. 
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Results 
Automatic assessment of disease severity in Congestive Heart Failure patients:  For the 
first time, a completely automatic method, based on long-term Heart Rate Variability  
measures, that is extracted from nominal 24-h electrocardiographic recordings, was 
proposed in order to automatically assess the severity of Congestive Heart Failure (mild 
versus severe disease). It has been developed by using public databases, freely available 
from the physionet.org website. Since the dataset is unbalanced, an approach based on 
feature selection and tree-based classifier was proposed and compared to standard 
methods to handle the imbalance problem. The proposed methods outperformed the 
standard methods selected as benchmark achieving a sensitivity rate of 93% and a 
specificity rate of 64% in discriminating severe versus mild patients.  
Automatic identification of hypertensive patients at high risk of vascular events: For the 
first time, a completely automatic system was proposed in order to identify hypertensive 
patients at higher risk to develop vascular events (e.g. stroke, myocardial infarction, 
syncope) in the 12 months following the electrocardiographic recordings. It was based on 
linear and nonlinear Heart Rate Variability analysis of a 5-minute ECG segment. A 
rigorous validation method, based on a crossvalidation loop nested in an hold-out 
splitting, was proposed to compare the performance of several data-mining algorithms, 
based on different approaches. The algorithms were trained on a database developed ad 
hoc, which is already available in Physionet.org website (PhysioNetWorks, i.e. area for 
registered users) and is planned to be published in the public area of the website. The 
proposed methods achieved a sensitivity rate of 71% and a specificity rate of 86% in 
identifying high risk subjects among hypertensive patients and outperformed the 
conventional echographic risk factors for vascular events.  
Automatic identification of hypertensive patients with history of fall: For the first time, it 
was explored whether an automatic identification of fallers among hypertensive patients 
based on Heart Rate Variability was feasible. The proposed method outperformed several 
functional tests which were proposed in literature for faller identification. Moreover, it 
does not require the use of other technologies as wearable accelerometers or pressure 
matrices, which are not used in everyday clinical practices, not having direct benefits for 
cardiovascular outpatients. 
Discussions and conclusions 
The results obtained in this thesis could have implications both in clinical practice and in 
clinical research. The system has been designed and developed in order to be clinically 
feasible. In particular, Heart Rate Variability analysis and the automatic system for 
identification of high-risk patients are integrated in a web-based platform, developed in 
the framework of the Smart Health and Artificial Intelligence for Risk estimation 
(SHARE) project. The platform, now integrated in an open and interoperable cloud 
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computing platform for health and eGovernement (PRISMA), included a standalone 
software (for Windows operative system) and an Android application to acquire signals 
from wearable devices.  This integration enable to test the clinical feasibility and uptake 
of the developed tool in a prospective study in subjects aged 55 and over recruited by the 
Center of Hypertension of the University Hospital of Naples Federico II. Moreover, since 
5-minute ECG recording is inexpensive, easy to assess, and non-invasive, future research 
will focus on the clinical applicability of the system as a screening tool in non-specialized 
ambulatories (e.g. at General Practitioners’), in order to identify high-risk patients to be 
shortlisted for more complex (and costly) investigations. Improved identification of 
individuals at risk for the development of vascular events may result in more targeted and 
adequate prevention strategies. For example, adopting the model for vascular risk 
assessment in a cohort of 1000 hypertensive patients, about 200 high risk subjects should 
be identified, and among them, 80 will develop a vascular event in the following 12 
months. Since, as reported by the European Guidelines on cardiovascular disease 
prevention in clinical practice, most of cardiovascular events could be avoided by changes 
in life styles and appropriate use of therapeutic treatments, it can be hypotized that the 
adoption of targeted strategies on the high-risk subjects could halve the number of 
vascular events. 
The findings obtained by the data-mining methods (which did not use any a priori 
knowledge) reinforce the previous clinical observation that depressed HRV is a marker 
of cardiovascular risk and, for the first time, showed that it could be also an interesting 
parameter to be investigated in fall identification and prevention research. In particular, 
the proposed method does not require the use of other technologies as wearable 
accelerometers or pressure matrices, which are not used in everyday clinical practices, 
not having direct benefits for cardiovascular outpatients. For that reason, the method 
proposed could be used widely in outpatient settings to identify high-risk patients who 
need further assessment and could benefit from fall prevention programs or fall detection 
systems.  
The main limitation of the achieved findings is the relatively small sample size of the 
datasets. This issue could be addressed in the next future by increasing the number of 
enrolled subjects by Center of Hypertension of the University Hospital of Naples Federico 
II. This would make the present findings clinically more relevant. Moreover, the dataset 
used in the fall identification issue was not specifically designed to study falls. Therefore, 
important information, such as the exposure to other independent intrinsic risk factors for 
falls could not be accessed or used to verify independently the results. Moreover, the fall 
recordings were based on patient self-reports, which are considered not every time 
reliable as some non-harmful falls can be forgotten and not reported. Therefore, the 
number of falls could have been underestimated.  
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Further developments of the current thesis could be the adoption of new Heart Rate 
Variability measures (e.g. point process time-frequency analysis), strong risk markers 
extracted from ECG (e.g. Heart Rate Turbulence or T wave alterations), and other non-
invasive measures obtained by wearable sensors (e.g accelerometric signals, breath rate). 
 
Outline 
The thesis is organized as follows:  
 in the chapter 1, the main topics which are addressed in the thesis, such as 
Autonomous Nervous System, Heart Rate Variability, cardiovascular diseases, 
are briefly introduced; 
 the adopted databases are described in the Chapter 2;  
 the adopted methods, including features computation and selection, machine 
learning algorithms, are reported in Chapter 3; 
 in the Chapter 4, the main results are presented and discussed in relation with the 
state of art; 
 the Chapter 5 provides the conclusions of the works. 
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1 Introduction 
1.1 Autonomic Nervous System 
The Autonomic Nervous System (ANS) innervates primarily the smooth musculature of 
all organs, the heart and the glands in order to mediate the neuronal regulation of the 
internal milieu. (Jänig, 1989)  The functions of the ANS are to keep the internal milieu of 
the body constant or adjust it as required by changing circumstances (e.g. mechanical 
work, stressful situation, food intake). The actions of ANS are in general not under direct 
voluntary control. The ANS consists of two subdivisions: the sympathetic and the 
parasympathetic nervous system.  
The nerves of the sympathetic system originate from the intermediate zone of the thoracic 
and lumbar spinal cord. The axons of these neurons are thin, but many are myelinated; 
their conduction velocities range from 1 to 20 m/s. They leave the spinal cord in the 
ventral roots and the white rami communicants, and terminate in the paired paravertebral 
ganglia or the unpaired paravertebral abdominal ganglia. The paravertebral ganglia are 
connected by nerve strands to form a chain on either side of the vertebral column. From 
these sympathetic trunks, the thinner, unmyelinated postganglionic axons either pass in 
the grey rami to the effectors in the periphery of the body, or form special nerves that 
supply organs in the head region or in the thorax, abdomen and pelvis.  
The cell bodies of the preganglionic parasympathetic neurons are in the sacral cord and 
the brainstem. All the axons are very long as compared with those of the sympathetic 
preganglionic neurons. They form special nerves to the parasympathetic postganglionic 
neurons, which are near or in the effector organs.  
The efficacy of the heart as pump is controlled by sympathetic and parasympathetic 
nerves, which supplied the heart. The parasympathetic nerves (the vagi) are distributed 
mainly to the sinoatrial and atrioventricular nodes, to a lesser extent to the muscle of the 
two atria, and very little directly to the ventricular muscle. The sympathetic nerves, 
conversely, are distributed to all parts of the heart, with strong representation to the 
ventricular muscle as well as to all the other areas. 
Stimulation of the parasympathetic nerves to the heart causes the hormone Acetylcholine 
to be released at the vagal endings. This hormone has two major effects on the heart. First, 
it decreases the rate of rhythm of the sinus node, and second, it decreases the excitability 
of the atrioventricular junctional fibers between the atrial musculature and the 
atrioventricular node, thereby slowing transmission of the cardiac impulse into the 
ventricles. Weak to moderate vagal stimulation slows the rate of heart pumping, often to 
as little as one half normal, and strong stimulation of the vagi can stop completely the 
rhythmical excitation by the sinus node or block completely transmission of the cardiac 
impulse from the atria into the ventricles through the atrioventricular mode. In either case, 
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rhythmical excitatory signals are no longer transmitted into the ventricles. The ventricles 
stop beating for 5 to 20 seconds, but then some point in the Purkinje fibers, usually in the 
ventricular septal portion of the atrioventricular bundle, develops a rhythm of its own and 
causes ventricular contraction at a rate of 15 to 40 beats per minute. This phenomenon is 
called ventricular escape.  
The acetylcholine released at the vagal nerve endings greatly increases the permeability 
of the fiber membranes to potassium ions, which allows rapid leakage of potassium out 
of the conductive fibers. This causes increased negativity inside the fibers, an effect called 
hyperpolarization, which makes this excitable tissue much less excitable. In the sinus 
node, the state of hyperpolarization decreases the “resting” membrane potential of the 
sinus nodal fibers to a level considerably more negative than usual, to -65 to -75 millivolts 
rather than the normal level of -55 to -60 millivolts. Therefore, the initial rise of the sinus 
nodal membrane potential caused by inward sodium and calcium leakage requires much 
longer to reach the threshold potential for excitation. This greatly slows the rate of 
rhythmicity of these nodal fibers. If the vagal stimulation is strong enough, it is possible 
to stop entirely the rhythmical self-excitation of this node. In the atrioventricular node, a 
state of hyperpolarization caused by vagal stimulation makes it difficult for the small 
atrial fibers entering the node to generate enough electricity to excite the nodal fibers. 
Therefore, the safety factor for transmission of the cardiac impulse through the 
transitional fibers into the atrio-ventricular nodal fibers decreases. A moderate decrease 
simply delays conduction of the impulse, but a large decrease blocks conduction entirely. 
Sympathetic stimulation causes essentially the opposite effects on the heart to those 
caused by vagal stimulation, as follows. First, it increases the rate of sinus nodal 
discharge. Second, it increases the rate of conduction as well as the level of excitability 
in all portions of the heart. Third, it increases greatly the force of contraction of all the 
cardiac musculature, both atrial and ventricular. In short, sympathetic stimulation 
increases the overall activity of the heart. Maximal stimulation can almost triple the 
frequency of heartbeat and can increase the strength of heart contraction as much as 
twofold. 
Stimulation of the sympathetic nerves releases the hormone norepinephrine at the 
sympathetic nerve endings. The precise mechanism by which this hormone acts on 
cardiac muscle fibers is somewhat unclear, but the belief is that it increases the 
permeability of the fiber membrane to sodium and calcium ions. In the sinus node, an 
increase of sodium-calcium permeability causes a more positive resting potential and also 
causes increased rate of upward drift of the diastolic membrane potential toward the 
threshold level for self-excitation, thus accelerating self-excitation and, therefore, 
increasing the heart rate. 
In the atrioventricular node and bundles, increased sodium-calcium permeability makes 
it easier for the action potential to excite each succeeding portion of the conducting fiber 
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bundles, thereby decreasing the conduction time from the atria to the ventricles. The 
increase in permeability to calcium ions is at least partially responsible for the increase in 
contractile strength of the cardiac muscle under the influence of sympathetic stimulation, 
because calcium ions play a powerful role in exciting the contractile process of the 
myofibrils. (Guyton and Hall, 2006) 
1.2 Heart Rate Variability 
Heart Rate Variability (HRV) is the variation over time of the period between consecutive 
heartbeats (RR intervals) (Malik et al., 1996) and is usually extracted from 
electrocardiographic signal recorded through a non-invasive technique. HRV is 
commonly used to assess the influence of the ANS on the heart (Malik et al., 1996). HRV 
is usually extracted by electrocardiographic signals (ECG). 
Many measures for assessing HRV have been described in literature, particularly with 
reference to their discrimination ability between different pathophysiological clinical 
conditions. In general, HRV measurement could be distinguished in: time-domain, 
frequency-domain and nonlinear measures. 
1.2.1 Time-domain HRV measures 
A number of standard statistical time-domain HRV measures have been proposed in 
literature:  
 the Standard Deviation of all NN intervals, which is the most simplest variable to 
calculate, but it is dependent from the length of recording period(Malik et al., 
1996);  
 the standard deviation of the average NN interval calculated over short periods, 
usually 5 min, which is an estimate of the changes in heart rate due to cycles longer 
than 5 min(Malik et al., 1996); 
 the mean of the 5-min standard deviation of the NN interval calculated over 24 h, 
which measures the variability due to cycles shorter than 5 min(Malik et al., 
1996); 
 the square root of the mean squared differences of successive NN intervals(Malik 
et al., 1996); 
 the number of times in which the change in successive normal sinus (NN) intervals 
exceeds 50 ms (Ewing et al., 1984); 
 percentage of differences between adjacent NN intervals that are longer than 50 
ms (pNN50) (Bigger et al., 1988); 
 the other measures of the pNNx familiy, where the threshold measure x is set to 
value different from 50 ms (Mietus et al., 2002). 
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Other time-domain measures are based on geometric methods, which can follow one of 
the following approaches: 
 a basic measurement of the geometric pattern (e.g. the width of the distribution 
histogram at the specified level) is converted into the measure of HRV;  
 the geometric pattern is interpolated by a mathematically defined shape (e.g. 
approximation of the distribution histogram by a triangle, or approximation of the 
differential histogram by an exponential curve) and then the parameters of this 
mathematical shape are used,  
 the geometric shape is classified into several pattern-based categories which 
represent different classes of HRV (e.g. elliptic, linear and triangular shapes of 
Lorenz plots) (Malik et al., 1996). 
The most common geometric measures are the following ones: 
 the HRV triangular index, i.e. the integral of the density distribution (computed 
as the number of all NN intervals) divided by the maximum of the density 
distribution of NN intervals(Malik et al., 1996). 
 the baseline width of the distribution measured as a base of a triangle, 
approximating the NN interval distribution (the minimum square difference is 
used to find such a triangle) (Malik et al., 1996). 
1.2.2 Frequency-domain HRV measures 
The frequency-domain HRV measures rely on the estimation of power spectral density 
(PSD). Several spectral methods have been applied for the PSD estimation and are usually 
distinguished in non-parametric and parametric. (Malik et al., 1996) The non-parametric 
method are based in most of the cases on the Fast Fourier Transform FFT and their 
advantages are: the simplicity of the algorithm employed and the high processing speed, 
but they suffer from spectral leakage effects due to windowing. The spectral leakage leads 
to masking of weak signal that are present in the data. The parametric methods (i.e. model 
based) avoid the problem of leakage and provide smoother spectral components which 
can be distinguished independently of preselected frequency bands, easy post-processing 
of the spectrum with an automatic calculation of low and high frequency power 
components and easy identification of the central frequency of each component, and an 
accurate estimation of PSD even on a small number of samples on which the signal is 
supposed to maintain stationarity. (Malik et al., 1996) The widely used parametric 
methods is the Autoregressive (AR) model. In AR method, the estimation of AR 
parameters can be done easily by solving linear equations. In AR method, data can be 
modeled as output of a causal, all pole, discrete filter whose input is white noise(Acharya 
et al., 2006) Formally, AR model is expressed by the following equation: 
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𝑥(𝑘) = − ∑ 𝑎(𝑛)𝑥(𝑘 − 𝑛) + 𝑤(𝑘)
𝑁
𝑛=1
 
where a(n) is AR coefficient and w(k) is white noise of σ2 variance and N is the order of 
the model. The parameters of the model are the AR coefficient and the variance σ2. The 
most relevant issue related to PSD estimation by AR model is the selection of the order 
N. Different studies investigated this issue, particularly, by using the Akaike information 
criteria, enabling to conclude that the model order could be set to 16. (Boardman et al., 
2002). 
Three main spectral components are distinguished in a spectrum calculated from short-
term recordings (2 – 5 minutes): very low frequency (VLF), low frequency (LF), and high 
frequency (HF) components(Akselrod et al., 1981). Spectral analysis may also be used to 
analyse the sequence in the entire 24-h period. The result then includes an ultra-low 
frequency component (ULF), in addition to VLF, LF and HF components. (Malik et al., 
1996)  
Moreover, the use of techniques such as the FFT require an evenly sampled time series. 
Since HRV is calculated from the variations in the RR interval series which are inherently 
irregularly spaced in time, in order to produce an evenly sampled time series prior to FFT-
based spectral estimation, linear or cubic spline resampling is usually employed.(Laguna 
et al., 1998). Ectopic beats, arrhythmic events, missing data and noise effects may alter 
the estimation of the PSD of HRV. Proper interpolation (or linear regression or similar 
algorithms) on preceding/successive beats on the HRV signals or on its autocorrelation 
function may reduce this error(Malik et al., 1996). A recent study(Clifford and 
Tarassenko, 2005) showed that Lomb-Scamble periodgram, a more appropriate spectral 
estimation technique for unevenly sampled time series that uses only the original 
data,(Lomb, 1976) provides a superior PSD estimate of RR series compared to FFT 
techniques, with reference to ectopic beat removal or replacement. 
1.2.3 Nonlinear HRV measures 
Recent developments in the theory of nonlinear dynamics have paved the way for 
analysing signals generated from nonlinear living systems(Acharya et al., 2006). It is now 
generally recognized that these nonlinear techniques are able to describe the processes 
generated by biological systems in a more effective way. The most common nonlinear 
techniques applied to HRV analysis are: Poincaré Plot(Brennan et al., 2001), 
Approximate Entropy(Richman and Moorman, 2000), Sample Entropy(Richman and 
Moorman, 2000), Correlation Dimension(Carvajal et al., 2005), Detrended Fluctuation 
Analysis(Peng et al., 1995a, Penzel et al., 2003), and Recurrence Plot (Trulla et al., 1996, 
Webber and Zbilut, 1994, Zbilut et al., 2002).  
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1.2.3.1 Poincaré Plot  
The Poincaré Plot, also known as return map, is a common graphical representation in 
which each point is represented as a function of the previous one. In HRV analysis, 
Poincaré Plot is the scatterplot of the successive RR versus previous one. A widely used 
approach to analyse the Poincaré plot of RR series consists in fitting an ellipse oriented 
according to the line-of-identity and computing the standard deviation of the points 
perpendicular to and along the line-of-identity referred as SD1 and SD2, 
respectively(Brennan et al., 2001). 
It has been shown that SD1 and SD2 are related to linear measures of HRV(Brennan et al., 
2001). Moreover, the two Poincaré Plot measures are related to the autocovariance 
function and, for that reason, these two Poincaré Plot measures could not provide 
independent nonlinear information and in recent review on HRV(Rajendra Acharya et al., 
2006) they are discussed in the standard time domain analysis instead of nonlinear 
methods. Two kind of generalization of the Poincaré Plot are proposed in the 
literature(Brennan et al., 2001): the lagged Poincaré Plot and the higher order Poincaré 
Plot.  
The lagged Poincaré Plot is the plot of RRn+m against RRn where m is chosen from 2 to 
some small positive value (not higher than 8). SD1 and SD2 are computed similarly as lag 
m set to 1 and are also related to the autocovariance function. For that reason, the set of 
lagged Poincaré Plot is a description of the autocovariance function.  
Poincaré Plot of order m is a m-dimensional scatter-plot of the m-ples (RRn, RRn+1,…, 
RRn+m). This plot resulted in 2-dimensional projection into each of the coordinate planes 
(RRn, RRn+1), (RRn+1, RRn+2),…,(RRn, RRn+m). The first two projections are equivalent to 
standard Poincaré Plot, the last one is equivalent to a Poincaré Plot with lag m, and the 
other projections are equivalent to Poincaré Plot with lag up to m. In other words, an order 
m Poincaré Plot is geometrically described by a set of Poincaré Plot with lag up to m+1. 
Geometrically, SD1 measures the width of the Poincaré cloud and, therefore, indicates the 
level of short-term HRV, while SD2 measures the length of the cloud along the line-of-
identity, reflecting the long-term HRV. Mathematically, the findings by Brennan et al. 
(Brennan et al., 2001) proposed the interpretation of SD1 as a measure of short-term (over 
each beat) variability, and of SD2 as a measure of the difference between total variability 
and short-term variability. This could be explained by considering a time series which 
shows variability only over a single beat, such as a sequence alternating between two 
value (RRI, RRII, RRI, RRII,…,RRI, RRII). The Poincaré Plot of this series shows a zero 
length and zero value of SD2, which are coherent with the absence of long-term 
variability, while the SD1 has a non-zero value, reflecting the short-term variability of the 
time series.  
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Others techniques, such as central tendency measure(Hnatkova et al., 1995), density 
based approach(Cohen et al., 1996), have been applied in order to extract independent 
nonlinear information from Poincaré Plot, but they are not as widely used as SD1 and 
SD2.  
1.2.3.2 Approximate entropy  
Approximate entropy (AppEn) is widely used method to measure the complexity of 
signal(Pincus, 1991). It shows the probability that similar observation patterns do not 
repeat. If a time series demonstrates complex, irregular behaviour, than it will have a high 
AppEn values. For instance, sinusoids give approximately zero value of AppEn. AppEn 
showed several advantages: it can be applied for both short-term and long-term 
recordings, it is scale invariant, model independent, easy to use and it is able to 
discriminate time series for which clear future recognition is difficult(Rajendra Acharya 
et al., 2006, Chon et al., 2009). For that reason, it has been applied in different fields, 
particularly in cardiovascular signal analysis to assess the irregularity of the RR 
series(Richman and Moorman, 2000).  
The AppEn computation rely on the values of two parameters: m, the embedding 
dimension, and r,  the tolerance threshold, which are required to be specified a priori. 
Several clinical studies(Pincus, 1991, Niskanen et al., 2004, Ho et al., 1997) have shown 
that either m=1 or 2 and r between 0.1 and 0.2 times the SDNN are suitable to provide 
valid value of AppEn. However, a recent study(Chon et al., 2009) recommended the use 
of the r value (rmax) which maximizes the AppEn (AppEnmax). This conclusion was derived 
by the observation that the AppEn computed with value of r within the recommended 
range 0.1 - 0.2 provided misleading results in simulated signals. The AppEn  determines 
the conditional probability of similarity between a chosen data segment of a given 
duration and the next segment set of the same duration; the higher the probability the 
smaller the AppEn value, reflecting less complexity. Applying AppEn to the following 
three time series with decreasing complexity:  white noise, cross chirp, and sinusoidal 
signals, AppEnmax provides higher values for white noise, then for cross chirp and lower 
value for sinusoidal signals, according to their decreasing complexity. If other values of 
r threshold are adopted, misleading results can arise, such as higher values for cross chirp 
than for white noise. Moreover, a previous study on human HRV data (Castiglioni and 
Di Rienzo, 2008) showed that a selection of r=0.25 resulted in a 12% decrease of AppEn 
values, whereas r=0.1 results in 9% increase as subjects changed their body position from 
supine to upright. The AppEnmax denotes the largest information difference between data 
length m and m+1 for any given r, reflecting the maximum complexity. However, the 
choice of AppEnmax is a computation burden and in order to avoid the computation of 
AppEn for each possible r value to find the maximum value, nonlinear models were 
proposed and validated to estimate rmax value from variability of the signals. In particular, 
for m=2, Chon et al.(Chon et al., 2009) proposed an empirical formula. However, a recent 
study by Liu(Liu et al., 2011) aimed to verify whether Chon’s method was appropriate 
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for HRV by comparing AppEn in two groups: healthy subject and patients suffering from 
cardiac disease. AppEn value were computed with three different value of the threshold r
: 
SDNNr *2.0  (AppEn0.2); 
maxrr  ; 
chonrr  (AppEnChon). 
Surprisingly, only AppEnChon (not AppEn0.2 nor AppEnmax) was statistically different 
between the two groups. Another recent study analysed the three different type of AppEn 
in healthy subjects under stress compared to controlled resting condition(Melillo et al., 
2011a). Also in this study, AppEnmax was not statistically different between the two 
groups, while statistically significant differences were observed in AppEn0.2 e AppEnChon. 
The findings of these studies could be explained according to the analysis of the Chon’s 
empirical formula, particularly, its relationship with the ratio between short-term and 
long-term variability. Further studies should focus on development of methods which can 
reduce the influence from the different threshold values r in AppEn computation.  
1.2.3.3 Sample entropy 
Sample Entropy (SampEn) is a relatively new feature introduced by Richman et 
al.(Richman and Moorman, 2000) to measure the complexity and the regularity of clinical 
time series. It is very similar to AppEn, with some important differences in its calculation. 
SampEn, in theory, does not depend on the length of the time series, but it also relies on 
the choice of the parameters m and r, such as AppEn. However, the dependence on the 
parameter r is different: SampEn decreases monotonically when r increases. With high 
value of N and r, SampEn and AppEn provide comparable results(Rajendra Acharya et 
al., 2006), for that reason, the applications of the two measures are very similar. 
1.2.3.4 Fractal Dimension, Correlation Dimension and Detrended Fluctuation Analysis  
The term “fractal” was first defined as a geometric concept(Mandelbrot, 1982), referring 
to an object satisfying two properties: self-similarity and fractional dimensionality. The 
former property means that an object is composed of subunits (and sub-subunits on 
multiple levels) that statically resemble the structure of the whole object. The latter 
property means that the object has a fractional dimension. For example, in bidimensional 
curve, to verify self-similarity, a subset of the object is rescaled to the same size of the 
original object, using the same magnification factor for both its width and height, and its 
statistical properties are compared with those of the original object. Mathematically, this 
property should hold on all scales, however, in the real world, there are necessarily lower 
and upper bounds over which such self-similar behaviour applies. Moreover, the strict 
criterion requires that all the statistical properties (including all higher moments) are 
identical. Therefore, in practice, a weaker criterion is adopted by examining only the 
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means and variances (first and second moments) of the distribution. The second criteria 
distinguishes fractal from Euclidean objects, which have integer dimension. For example, 
a square satisfies self-similarity as it can be divided into smaller subunits that resemble 
the large square, but it is not a fractal since it has an integer (2) dimension. Fractal-like 
appearance was observed in several cardiovascular structures, such as the arterial and 
venous tree and His-Purkinje network.  
The concept of fractal has been extended to the analysis of time series. For instance, in 
order to verify self-similarity in time series, a subset of the time series is selected and 
rescaled, but with two different magnification factors (since the two axes have 
independent physical units). Mathematically, a time series is self-similar if 
𝑥(𝑡) ≡ 𝑎𝑎𝑥 (
𝑡
𝑎
) 
where a is the self-similarity parameter or scaling exponent and the operator ≡ indicate 
that the statistical properties of both side of the equation are identical; however, as already 
stated, in practice, only the first and second moment statistical properties are compared. 
The scaling exponent could be estimated by Detrended Fluctuation Analysis, while the 
Higuchi’s algorithm could be adopted for estimation of the fractal dimension 
(FD)(Higuchi, 1988). The correlation dimension CD is one of the most widely used 
measures of the fractal dimension and has been adopted to measure the complexity for 
the HRV time series(Carvajal et al., 2005).  
Detrended Fluctuation Analysis is used to quantify the fractal scaling properties of short 
RR time series, by measuring the correlation within the signal(Penzel et al., 2003, Peng 
et al., 1995a). It is a modified version of root-mean-square analysis of random 
walks(Huikuri et al., 2000) and consists into: integration of the root-mean-square 
fluctuation, computation of detrended time series at observation window of different size 
and plot against the windows sizes on a log-log scale and the scaling exponent α is 
computed the slope of the regression line. The value of α for white noise, for fractal-like 
signal and Brownian noise (integral of Gaussian noise) are 0.5, 1 and 1.5, 
respectively(Huikuri et al., 2000, Ho et al., 1997). In HRV analysis, other two additional 
indexes are usually computed(Schulz et al., 2010, Peng et al., 1995b): short-term 
fluctuations (Alpha1) and long-term fluctuations (Alpha2). 
1.2.3.5 Recurrence Plot 
Recurrence Plot was introduced by Eckmann et al.(Eckmann et al., 1987) as a graphical 
tool to discover hidden periodicities, difficult to be detected otherwise, and can be used 
to reveal non-stationarity in the time series. The recurrence plot is an array of dots in an 
N x N square, where a dot is placed at (i,j) whenever RRj is sufficiently close to RRi. The 
plots will be symmetric along the diagonal i = j, because if RRi is close to RRj, then RRj 
is close to RRi. For normal cases, the Recurrence Plot has diagonal line and less squares 
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indicating more variation indicating high variation in the heart rate. Abnormalities like 
ischemic/dilated cardiomyopathy cases, show more squares in the plot indicating the 
inherent periodicity and the lower heart rate variation(Acharya et al., 2006). 
1.3 Congestive Heart Failure 
Congestive Heart Failure (CHF) is a patho-physiological condition due to an abnormal 
cardiac function, which is responsible for the failure of the heart to pump blood as 
required by the body. It is a common end-stage of heart disease, greatly shortening 
survival. CHF is associated with profound derangements of the ANS, which worsen 
disease progression(Cohn, 1990). Sympathetic tone is markedly increased while 
parasympathetic modulation of heart rate is markedly decreased(Floras, 1993). 
Hemodynamic and metabolic abnormalities probably serve as the afferent stimulus for 
this response. This chronic activation is accompanied by an attenuation of reflex 
responsiveness to unloading of the central baroreceptors and mechanoreceptors. Loss of 
the buffering capacity of these afferent receptors may contribute to the sustained 
sympathetic stimulation. The renin-angiotensin system is uncoupled from the sympathetic 
nerves, probably because the intrarenal mechanisms subserving renin release are 
preserved. Chronic activation of the sympathetic nerves may contribute to disturbed 
hemodynamics as well as to long-term structural changes that may influence the natural 
history of the disease. (Cohn, 1990) 
CHF severity can be measured with the symptomatic classification scale of the New York 
Heart Association (NYHA) (Fleg et al., 2000). Classification via NYHA scale has been 
proved to be a risk factor for mortality (Redfield et al., 1998, Gheorghiade et al., 2005).  
NYHA functional classification identifies patients in one of four categories based on 
physical symptoms and activity restriction:  
 Class I – No symptoms with ordinary activity. No limitations on activity  
 Class II – Slight to moderate symptoms with normal activity. Slight limitation of 
activity. 
 Class III – Moderate symptoms with less than normal activity. Marked limitation 
of activity.  
 Class IV – Inability to carry out any physical activity without discomfort. 
Symptoms may occur at rest(Carels, 2004). 
1.4 Hypertension and risk assessment  
Hypertension is the most common cardiovascular disease. Hypertension is defined as 
values higher than 140mmHg for systolic blood pressure and/or higher than 90mmHg for 
diastolic blood pressure. Limited comparable data are available on the prevalence of 
hypertension and the temporal trends of blood pressure values in different European 
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countries(Pereira et al., 2009). Overall, the prevalence of hypertension appears to be 
around 30–45% of the general population, with a steep increase with ageing.  
1.4.1 Cardiovascular risk estimation  
Estimation of total cardiovascular risk is easy in particular subgroups of patients, such as 
those with antecedents of established cardiovascular disease, diabetes, or with severely 
elevated single risk factors. In all of these conditions, the total cardiovascular risk is high 
or very high, calling for intensive cardiovascular risk-reducing measures. However, a 
large number of patients with hypertension do not belong to any of the above categories 
and the identification of those at low, moderate, high or very high risk requires the use of 
models to estimate total cardiovascular risk, so as to be able to adjust the therapeutic 
approach accordingly. 
Several risk estimation system have been developed(Pyorala et al., 1994, D'Agostino et 
al., 2008, Conroy et al., 2003, Woodward et al., 2007, Hippisley-Cox et al., 2008, 
Assmann et al., 2002, Ridker et al., 2008, Ridker et al., 2007) and their values and 
limitations have been reviewed recently(Cooney et al., 2009). Most of the current risk 
estimation systems include the conventional risk factors: age, sex, smoking, blood 
pressure, and lipid levels. Recently, there has also been increasing interest in the inclusion 
of family history of chronic heart disease (Woodward et al., 2007, Hippisley-Cox et al., 
2008, Ridker et al., 2008, Ridker et al., 2007), social deprivation measures (Woodward et 
al., 2007, Hippisley-Cox et al., 2008), ethnicity(Hippisley-Cox et al., 2008), and 
interaction variables that adjust for the use of antihypertensive medication (Woodward et 
al., 2007, Hippisley-Cox et al., 2008, Wilson et al., 1998). 
Most of the current risk estimation systems are based on proportional hazards models, 
such as Cox (semiparametric) or Weibull (parametric). The Cox method has the 
advantage of not making any assumptions regarding the shape of the underlying survival, 
in contrast to the Weibull method, which imposes a parametric function on the baseline 
survival. One limitation of all risk estimation systems is that they assume constant effects 
of the risk factors at differing ages and levels of the other risk factors. One system 
(QRISK2) has attempted to overcome the problem of differing effects of the risk factors 
with increasing age by including interaction variables between age and several of the 
other risk factors(Hippisley-Cox et al., 2008). However, this method still assumes that the 
interaction effect with age remains constant at all ages. Certain combinations of risk 
factors may act synergistically to increase risk in a manner that is more than additive. 
Some data-mining methods, such as cluster analysis, neural networks and tree-based 
algorithm, attempt to account for this. These methods are particularly useful for selecting 
the most appropriate variables when a large number of potential predictors of risk are 
available. Neural networks do not assume that risk factors function in a constant and 
continuous fashion and can account for complex nonlinear relationships and interactions 
between risk factors. Cluster analysis focuses on the identification of groups of persons 
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with similar risk factor characteristics who have similar levels of risk. Tree-based 
algorithms attempt to progressively split the population into smaller subgroups, through 
sequential introduction of the risk factors, starting with the simplest. The advantage is 
that some persons can be classified as high or low risk based on very few risk factors, 
reducing unnecessary laboratory testing for them. However, these methods introduce 
other problems. The main problem with all of these methods is model shrinkage, that is, 
their predictive ability declines sharply once the model is applied to an external dataset, 
which limits their utility in clinical practice. Moreover, there is difficulty in obtaining 
large epidemiological datasets with extensive numbers of predictor variables available.  
Additionally, the necessity for measurement of multiple factors in clinical practice adds 
to complexity and is, therefore, likely to limit clinical usage of these systems. 
1.4.2 Fall risk 
Falls represent one of the most common causes of injury-related morbidity and mortality 
in later life. The consequences of falls range from psychological harm, through serious 
physical injuries (Lord et al., 2006) and hospitalization, to death (Rubenstein, 2006), 
often causing a reduction of independence in the faller. Falls reduce overall well-being, 
mobility and quality of life, of individuals and families (Katz and Shah, 2010). The mean 
and median costs of a fall is about 9,000 and 11,000 euro (Siracuse et al., 2012). 
Over 400 risk factors for falls have been identified and classified as either extrinsic, such 
as environment and circumstances, or intrinsic, which include deterioration of 
neurological functioning and sensory and/or cardiovascular impairments. The 
prioritization of those risk factors remains unclear and the sensitivity, specificity and 
applicability of subject-specific assessment of fall risk remains imprecise (Pecchia et 
al., 2011, Gates et al., 2008). 
Only 31% of falls appear to be due to accidents (Rubenstein, 2006) and also those 
accidental falls may be due to complex and dynamic unrevealed interactions between 
intrinsic and extrinsic risk factors (guidelines, 2013). According to Rubens(Rubenstein, 
2006), 42% of falls are due to transient problems, including: gait/balance disorders or 
weakness (17%), dizziness/vertigo (13%), drop attacks (9%), postural hypotension (3%). 
For that reason, ANS disturbance and cardiovascular disorders including carotid sinus 
hypersensitivity, serious arrhythmias, severe valvular heart disease, and coronary heart 
disease may be underestimated causes of falls(Isik et al., 2012). 
Several test have been developed for assessing mobility, some of which have also been 
suggested as predictor of falls(Tiedemann et al., 2008): 
 Sit-to-stand test: this test is used as a measure of lower limb strength (Csuka and 
McCarty, 1985) and is included in fall risk assessment scales(Tinetti, 1986, Berg 
et al., 1992, Smith, 1994). For the sit-to-stand test with five repetitions (STS-5), 
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subjects were asked to rise from a standard height (43 cm) chair without armrests, 
five times, as fast as possible with their arms folded. Subjects undertook the test 
barefoot and performance was measured in seconds, as the time from the initial 
seated position to the final seated position after completing five stands. The single 
sit-to-stand task (time from sitting to standing) (STS-1) was also evaluated as it 
has been used in assessment scales(Berg et al., 1992, Judge et al., 1996) as a 
measure of functional mobility, balance and lower limb strength. 
 Pick-up-weight test: The ability to reach down and pick up an object from the 
floor has been included in several mobility assessment scales (Berg et al., 1992, 
Reuben and Siu, 1990). A bag containing a 5 kg weight with handles that extended 
50 cm above the floor was placed on the floor in front of the subject. The subjects 
were asked to pick up the bag and place it on a table using one hand only. 
Performance was rated as either able or unable to complete the task. 
 Half-turn test: The ability to turn around in an efficient manner has been included 
in assessments of mobility and balance in older people(Berg et al., 1992, 
Podsiadlo and Richardson, 1991). Subjects were asked to take a few steps and 
then turn around to face the opposite direction. The number of steps taken to 
complete this 180° turn was counted. 
 Alternate-step test: The alternate-step test (AST) is a modified version of the Berg 
stool-stepping task(Berg et al., 1992). It involves weight shifting and provides a 
measure of lateral stability. This test involved alternatively placing the entire left 
and right feet (shoes removed) as fast as possible onto a step that was 18 cm high 
and 40 cm deep. The time taken to complete eight steps, alternating between the 
left and right feet comprised the test measure.  
 Six-metre-walk: Slow gait speed is associated with an increased risk of falls 
(Imms and Edholm, 1981, Bootsma-van der Wiel et al., 2002) and is a measure 
included in fall risk assessment scales (Podsiadlo and Richardson, 1991, 
Piotrowski and Cole, 1994). Subjects completed a six-metre-walk test (SMWT) 
measured in seconds along a corridor at their normal walking speed. A 2-m 
approach and a further 2 m beyond the measured 6-m distance ensured that 
walking speed was constant across the 6 m. 
 Stair ascent and descent: The inability to negotiate stairs is a marker of functional 
decline in older people (Guralnik et al., 1994) and many falls occur during this 
task(Facts, 1996). The test stairs were indoors, had a handrail, were covered with 
linoleum and well lit. The subjects started the stair-ascent test at the bottom of 
eight steps (15 cm high, 27.5 cm deep). Subjects could use the handrail if preferred 
and a walking aid if they normally used one. Timing commenced for the stair-
ascent test when the subject raised their foot off the ground to climb the first step 
and stopped when both feet were placed on the eighth step (which was a landing). 
After a brief rest, the subject was asked to descend the stairs. Timing was started 
when they raised their foot off the ground for the first step and stopped when they 
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completed the last step. Time taken to complete the ascent and descent tests was 
recorded. 
A recent study (Tiedemann et al., 2008) compared these functional tests and showed that, 
when dichotomised, the AST was the best test for discriminating between the faller 
groups. An AST cut-off point of 10 s was associated with a 130% increased risk, with 
69% sensitivity and 56% specificity with respect to identifying multiple fallers. At 
identified cut-off points, the STS-5 (12 s), the SMWT (6 s), the stair-descent test (5 s) and 
the stair-ascent test (5 s) could also significantly predict subjects who suffered multiple 
falls with sensitivities and specificities above 50%.  
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2 Databases 
In the current chapter, the characteristics of the ECG holter databases that have been used 
for this thesis work are presented. Table 2.1 reported the summary properties of each 
database that will be then detailed in the following sections. 
Table 2.1 Summary of the adopted database 
Database Number of subjects Clinical Condition Availability 
Congestive Heart Failure 
RR Interval Database 
29 (aged 34 to 79; 
8 male, 2 female) 
CHF 
www.physionet.org 
(PhysioBank:  
Public data archives) 
BIDMC Congestive Heart 
Failure Database. 
15 (aged 22 to 71; 
11 male, 4 female) 
CHF 
www.physionet.org 
(PhysioBank:  
Public data archives) 
ECG Holter database  
for Vascular Events 
139 (age: 72 ± 7 years; 
90 male, 49 female) 
Hypertension with or 
without vascular events 
www.physionet.org 
(PhysioNetWorks,  
for registered users) 
ECG Holter database  
for Fall Risk 
168 (age: 72 ± 8 years; 
108 male, 60 female) 
Hypertension with or 
without history of fall 
progettoshare.it 
(by request) 
2.1 Congestive Heart Failure Holter databases 
2.1.1 Background and rationale 
For the investigation of ECG holter in CHF patients, two databases are freely available 
from physionet.org(Goldberger et al., 2000):  
 Congestive Heart Failure RR Interval Database  
 BIDMC Congestive Heart Failure Database. 
2.1.2 Population 
The Congestive Heart Failure RR Interval Database provides the RR time-series for 29 
long-term ECG recordings of subjects aged 34 to 79, with CHF (NYHA classes I, II, and 
III). Subjects included 8 men and 2 women; gender is not known for the remaining 21 
subjects. The BIDMC Congestive Heart Failure Database includes long-term ECG 
recordings from 15 subjects (11 men, aged 22 to 71, and 4 women, aged 54 to 63) with 
severe congestive heart failure (NYHA class 3-4). 
2.1.3 Protocol and measurement system 
The original ECG recordings, even if are not available, of the Congestive Heart Failure 
RR Interval Database were digitized at 128 samples per second, and the beat annotations 
were obtained by automated analysis with manual review and correction. The database is 
contributed by Rochelle Goldsmith, of Columbia-Presbyterian Medical Center, New 
York. The individual recordings of the BIDMC Congestive Heart Failure Database are 
each about 20 hours in duration, and contain two ECG signals each sampled at 250 
samples per second with 12-bit resolution over a range of ±10 millivolts. The original 
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analog recordings were made at Boston's Beth Israel Hospital (now the Beth Israel 
Deaconess Medical Center) using ambulatory ECG recorders with a typical recording 
bandwidth of approximately 0.1 Hz to 40 Hz. The RR time-series were obtained using an 
automated detector (without manual review and correction) 
2.2 ECG Holter database for Vascular Events 
2.2.1 Background and rationale 
Previous studies showed that HRV could be an independent risk factor for vascular 
events: Sajadieh et al. showed that subjects with familial predisposition to premature heart 
attack and sudden death have reduced HRV(Sajadieh et al., 2003); Dekker et al. 
concluded that low HRV is associated with increased risk of coronary heart disease and 
death from several causes (Dekker et al., 2000). Binici et al. demonstrated that depressed 
nocturnal heart rate variability is a strong marker for the development of stroke in 
apparently healthy subject (Binici et al., 2011). Since hypertension is a risk factor for 
vascular events and to the best of authors’ knowledge, no public database of hypertensive 
patients with a follow-up after the recording is freely available, a database of ECG holter 
recorded in hypertensive patients were collected ad hoc in order to investigate future 
vascular events in a twelve month follow-up.  
2.2.2 Population 
The records have been collected among the hypertensive patients aged 55 or over, 
followed up by the outpatient hypertension centre of the University Hospital of Naples 
Federico II. The recordings have been performed between 1 January 2012 and 10 
November 2012.  
The following exclusion criteria have been adopted: 
 refusal of written informed consent; 
 severe ocular disease; 
 deafness in alone living subject; 
 chronic obstructive pulmonary disease, (pre)dementia, or other disease which may 
reduce life expectancy. 
The dataset consists of 139 hypertensive patients (including 49 female and 90 male, age 
72 ± 7 years). Clinical and demographic features of the included subjects are reported in 
Table 2.2. Among the study sample, in the 12-month follow-up after recordings, 17 
patients experienced a recorded event (11 myocardial infarctions, 3 strokes, 3 syncopal 
events) and for that reason, were considered as high-risk subjects, while the remaining 
ones as low-risk subjects.
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Table 2.2  Clinical and demographic feature of the subjects included in the ECG Holter database for Vascular Events 
ID Sex Age Weight Height BSA1 BMI2 Smoker F hyp3 F stroke4 SP5 DP6 IMT7 LVMi8 EF9 Vascular event 
1911 M 56 105 180 2.29 32.41 yes no no 140 80 4 123 66 none 
2012 M 72 83 169 1.97 29.06 no no no 130 75 n/a 121 69 none 
2019 F 80 80 165 1.91 29.38 no no no 177 75 2.5 164 56 none 
2020 M 77 88 178 2.09 27.77 no no no 140 85 2.7 115 67 none 
2025 F 66 80 174 1.97 26.42 no no no 110 65 1.5 98 66 none 
2031 M 84 72 170 1.84 24.91 no no no 120 70 2.6 147 51 none 
2032 F 66 85 160 1.94 33.20 no no no 150 65 1.6 178 53 none 
2033 M 77 82 169 1.96 28.71 no no yes 115 80 n/a 144 42 myocardial infarction 
2035 M 77 80 162 1.90 30.48 no yes yes 160 75 n/a 123 70 none 
2037 F 69 90 154 1.96 37.95 no yes no 110 65 1.5 124 64 none 
2041 M 85 97 165 2.11 35.63 no no no 135 75 3 159 50 none 
2047 F 69 83 173 2.00 27.73 no no no 146 80 1.9 86 68 none 
2050 M 73 68 167 1.78 24.38 no yes no 105 70 1.7 202 43 none 
2055 M 65 72 167 1.83 25.82 no no no 130 85 2.3 106 68 none 
2057 F 66 72 176 1.88 23.24 no yes no 130 85 2 117 66 none 
2059 F 75 80 150 1.83 35.56 no no no 170 80 n/a 154 71 myocardial infarction 
2062 M 72 93 187 2.20 26.59 no no no 120 80 1.4 126 65 none 
2063 M 70 82 178 2.01 25.88 no yes no 162 100 1.6 153 62 none 
2065 F 69 81 170 1.96 28.03 no yes yes 135 65 2.7 105 66 none 
                                                 
1 Body surface area 
2 Body Mass index 
3 Family history of hypertension 
4 Family history of stroke 
5 Systolic arterial pressure 
6 Diastolic arterial pressure 
7 Intima media thickness 
8 Left ventricular mass index 
9 Ejection fraction 
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ID Sex Age Weight Height BSA1 BMI2 Smoker F hyp3 F stroke4 SP5 DP6 IMT7 LVMi8 EF9 Vascular event 
2066 M 74 74 165 1.84 27.18 no no no 130 80 3.1 121 63 none 
2068 M 67 72 171 1.85 24.62 yes yes no 120 85 n/a 144 61 none 
2069 M 64 86 178 2.06 27.14 no no no 115 75 2.2 111 61 none 
2072 M 73 64 174 1.76 21.14 yes no no 125 75 1.2 119 67 none 
2073 M 73 60 167 1.67 21.51 no no no 195 95 2.4 141 32 none 
2076 M 68 62 165 1.69 22.77 yes no no 143 62 3.7 168 33 none 
2078 M 74 85 180 2.06 26.23 yes yes no 150 75 1.7 140 67 none 
2079 M 71 113 168 2.30 40.04 no no no 150 85 2.6 156 67 none 
2082 M 58 92 175 2.11 30.04 yes yes no 135 70 1.6 98 69 none 
2084 F 70 93 165 2.06 34.16 no yes no 140 70 2.2 n/a n/a none 
2087 F 71 74 172 1.88 25.01 no yes no 160 75 2.3 126 65 none 
2089 F 75 68 156 1.72 27.94 yes no no 135 65 1.7 93 64 none 
2092 F 73 98 170 2.15 33.91 no yes no 155 78 2.9 129 65 none 
2097 M 79 81 172 1.97 27.38 yes no no 110 80 2.4 125 46 none 
2100 F 64 83 155 1.89 34.55 yes no no 200 80 3.3 156 62 none 
2102 M 74 74 172 1.88 25.01 no yes no 150 90 n/a n/a n/a none 
2107 M 76 70 160 1.76 27.34 no yes yes 145 75 3 146 60 none 
2108 M 84 70 170 1.82 24.22 yes no no 164 54 3.5 194 63 myocardial infarction 
2114 F 72 55 160 1.56 21.48 yes yes no 160 80 3 99 65 none 
2115 M 75 75 172 1.89 25.35 yes no no 122 74 3.3 121 68 none 
2116 M 65 98 171 2.16 33.51 no no no 130 80 1.7 125 54 none 
2117 M 69 65 175 1.78 21.22 no yes no 140 80 2.3 113 38 none 
2119 F 74 91 162 2.02 34.67 no no no 140 80 2.3 101 72 stroke 
2120 F 81 76 158 1.83 30.44 no yes no 160 80 2 163 66 none 
2121 M 81 93 170 2.10 32.18 yes no no 170 75 5 159 62 myocardial infarction 
2125 F 72 78 158 1.85 31.24 no yes no 190 80 4.2 154 72 none 
2134 F 86 78 160 1.86 30.47 no yes no 145 55 2.2 122 59 none 
2136 M 77 84 173 2.01 28.07 no no yes 155 85 2 154 66 none 
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ID Sex Age Weight Height BSA1 BMI2 Smoker F hyp3 F stroke4 SP5 DP6 IMT7 LVMi8 EF9 Vascular event 
2139 M 64 75 165 1.85 27.55 no no no 140 90 2.1 113 64 none 
2140 M 70 91 187 2.17 26.02 no no no 145 85 2.3 127 65 none 
2142 M 71 80 160 1.89 31.25 no no yes 165 80 3.3 152 53 none 
2148 F 66 64 156 1.67 26.30 no no no 130 75 2 129 60 myocardial infarction 
2150 M 59 68 164 1.76 25.28 yes no yes 100 60 1.4 98 69 none 
2152 F 82 64 156 1.67 26.30 no no no 110 70 1.6 159 65 none 
2154 M 80 75 167 1.87 26.89 yes no no 105 65 2.3 117 52 none 
2156 M 69 80 165 1.91 29.38 yes no no 150 90 2.5 n/a n/a none 
2159 M 75 68 169 1.79 23.81 no yes no 160 90 2.7 107 70 none 
2161 M 74 78 166 1.90 28.31 no yes no 130 70 2.4 122 56 none 
2167 M 77 80 169 1.94 28.01 yes no no 170 70 3 128 62 none 
2168 M 83 75 170 1.88 25.95 no no no 145 70 3.3 129 58 none 
2170 F 65 59 154 1.59 24.88 no no no 145 65 1.8 n/a n/a none 
2171 M 77 89 163 2.01 33.50 no no no 125 80 1 118 69 none 
2175 M 69 75 169 1.88 26.26 yes no no 150 86 2.2 n/a n/a none 
2180 M 69 88 171 2.04 30.09 no yes no 120 70 1.7 133 62 none 
2184 F 68 55 165 1.59 20.20 no yes no 110 70 1.35 98 68 myocardial infarction 
2185 M 81 72 171 1.85 24.62 yes yes no 145 80 2.9 148 60 myocardial infarction 
2186 F 65 67 159 1.72 26.50 no yes no 135 75 3.6 116 73 none 
2188 F 85 75 160 1.83 29.30 no no no 130 80 3.5 131 36 none 
2191 M 73 92 173 2.10 30.74 no yes yes 155 85 3.6 139 52 none 
2194 F 68 95 162 2.07 36.20 no yes no 145 75 1.8 118 72 none 
2202 M 63 72 168 1.83 25.51 no yes yes 135 85 1.4 n/a n/a none 
2210 F 80 58 153 1.57 24.78 no no no nan nan n/a n/a n/a none 
2213 M 65 82 175 2.00 26.78 no yes no 120 80 2.5 154 56 none 
2215 m 92 62 165 1.69 22.77 no no no 120 80 3 126 57 none 
2218 F 77 64 160 1.69 25.00 no yes no 110 60 1.5 146 70 syncope 
2219 F 75 72 162 1.80 27.43 no no no 150 75 1.4 149 45 none 
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ID Sex Age Weight Height BSA1 BMI2 Smoker F hyp3 F stroke4 SP5 DP6 IMT7 LVMi8 EF9 Vascular event 
2220 M 73 87 178 2.07 27.46 no yes no 175 65 1.8 233 53 none 
2226 M 65 83 165 1.95 30.49 yes no no 125 80 3.4 151 49 none 
2227 M 65 70 163 1.78 26.35 yes yes no 150 80 n/a 108 72 none 
2229 M 64 80 164 1.91 29.74 no no no 170 95 2.2 175 42 none 
2230 F 67 65 159 1.69 25.71 yes no no 100 60 2.5 116 67 none 
2231 F 69 80 159 1.88 31.64 no no no 142 82 2.2 133 66 none 
2244 M 86 73 168 1.85 25.86 yes no no 125 60 2.6 146 57 none 
2245 M 68 70 165 1.79 25.71 no no no 120 70 2.1 119 72 none 
2248 F 69 76 158 1.83 30.44 no yes no 150 90 2.5 126 66 none 
2249 F 66 89 167 2.03 31.91 no no no 120 70 1.9 175 28 none 
2250 M 66 100 170 2.17 34.60 no no no 135 75 1.6 166 47 none 
2251 M 84 83 181 2.04 25.34 yes no no 140 75 2.6 140 68 none 
2258 M 72 92 170 2.08 31.83 no no no 115 65 3.2 143 32 none 
2259 M 78 68 162 1.75 25.91 no no no 130 70 2 131 67 none 
2269 M 66 86 167 2.00 30.84 yes yes no 140 60 2.8 142 62 none 
2274 F 68 58 158 1.60 23.23 yes yes no 130 70 2.1 120 53 none 
2275 M 68 78 172 1.93 26.37 yes no no 135 85 1.6 127 52 none 
2276 F 77 54 160 1.55 21.09 no yes no 136 75 2 201 60 none 
2278 M 77 87 170 2.03 30.10 no yes yes 120 75 1.8 135 59 none 
2282 F 65 60 150 1.58 26.67 no no no 165 90 2 113 67 none 
2284 M 79 70 170 1.82 24.22 no no no 135 80 2.8 n/a n/a none 
2285 F 69 60 167 1.67 21.51 no yes no 110 80 1.6 90 68 none 
2289 F 64 98 165 2.12 36.00 no no yes 175 80 1.9 130 62 myocardial infarction 
2291 M 74 75 170 1.88 25.95 yes no no 145 85 2.2 144 62 none 
2293 M 81 68 166 1.77 24.68 no no no 130 85 2.3 141 33 none 
2294 M 67 61 165 1.67 22.41 no no no 120 80 2.8 126 25 stroke 
2295 M 64 88 173 2.06 29.40 yes no yes 115 60 2.3 n/a n/a none 
2296 M 74 83 170 1.98 28.72 no no no 145 85 1.5 120 48 none 
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ID Sex Age Weight Height BSA1 BMI2 Smoker F hyp3 F stroke4 SP5 DP6 IMT7 LVMi8 EF9 Vascular event 
2298 F 66 64 160 1.69 25.00 no no no 140 60 3 96 69 none 
2299 F 78 50 165 1.51 18.37 no no no 110 60 1.1 91 69 none 
2304 F 84 75 160 1.83 29.30 no yes yes 170 80 0.95 154 59 myocardial infarction 
2306 M 66 86 165 1.99 31.59 no no no 125 70 1.5 118 62 none 
2307 F 65 50 156 1.47 20.55 yes yes no 100 60 1 92 62 none 
2309 M 74 79 172 1.94 26.70 no no no 100 60 n/a 113 64 none 
2312 F 63 75 168 1.87 26.57 no no no 120 80 1.1 99 72 none 
2315 M 73 80 178 1.99 25.25 no no no 135 80 2.4 103 67 none 
2319 F 69 68 160 1.74 26.56 no no no 120 70 3.2 105 64 none 
2321 M 63 83 178 2.03 26.20 yes yes no 140 80 1.5 161 43 none 
2323 M 77 77 168 1.90 27.28 no no no 125 85 n/a n/a n/a none 
2328 M 46 77 172 1.92 26.03 yes no no 145 75 3.3 108 68 none 
2332 M 78 72 174 1.87 23.78 no no no 155 75 2 127 66 none 
2334 F 73 63 173 1.74 21.05 no yes no 140 70 2 137 60 none 
2337 M 65 84 168 1.98 29.76 yes yes no 150 90 2.8 167 38 none 
2338 M 76 74 170 1.87 25.61 no yes no 115 70 1.9 113 61 none 
2339 M 76 85 172 2.02 28.73 yes no no 120 70 3.8 184 33 syncope 
2348 M 72 65 168 1.74 23.03 yes yes no 135 70 2.5 118 62 stroke 
2349 M 65 107 170 2.25 37.02 no no no 130 85 2 146 64 none 
2350 F 81 94 162 2.06 35.82 yes no no 130 80 3.2 102 63 none 
2352 M 75 90 182 2.13 27.17 no no no 150 80 n/a 111 66 none 
2355 F 69 85 165 1.97 31.22 no no no 120 66 1.8 109 62 none 
2357 M 74 82 173 1.99 27.40 no no no 145 80 2.4 104 65 none 
2359 M 69 69 165 1.78 25.34 yes no no 135 75 3 125 60 none 
2370 F 64 63 162 1.68 24.01 yes no no 135 80 n/a 75 76 none 
2373 M 66 88 173 2.06 29.40 no no no 135 80 1.3 132 55 myocardial infarction 
2384 M 83 76 180 1.95 23.46 no no no 110 70 3.3 161 47 none 
2387 M 68 84 180 2.05 25.93 yes no no 155 85 2.6 121 33 none 
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2392 M 70 76 172 1.91 25.69 no no no 120 80 3.1 140 54 none 
2396 M 69 90 165 2.03 33.06 no no no 150 90 4 124 61 none 
2399 F 65 72 159 1.78 28.48 no yes no 150 90 3 105 67 none 
2403 F 78 55 157 1.55 22.31 no yes no 170 60 2.3 136 64 syncope 
2412 M 70 98 176 2.19 31.64 no yes no 130 75 2.2 131 54 myocardial infarction 
2413 M 78 74 170 1.87 25.61 no no no 125 65 2.3 170 32 none 
2417 M 65 93 175 2.13 30.37 no no no 120 80 1.7 112 65 none 
2425 M 67 67 170 1.78 23.18 yes no no 120 80 n/a n/a n/a none 
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2.2.3 Protocol and measurement system 
The ECG Holter was performed after a one-month antihypertensive therapy wash-out. On 
2 consecutive days, patients underwent a 24-hour ECG Holter recording. The recorders 
were applied between 9 and 11 AM on a working day, and the patients were asked to 
follow as closely as possible their usual daily activities during each monitoring session. 
They were asked to stay in bed from 11 PM to 7 AM.  The patients were followed up for 
12 months after the recordings in order to record major cardiovascular and 
cerebrovascular events, i.e. fatal or non-fatal acute coronary syndrome including 
myocardial infarctions, syncopal events, coronary revascularization, fatal or non-fatal 
stroke and transient ischemic attack. All the events were adjudicated by the Committee 
for Event Adjudication in the Hypertension Center. Adjudication was based on patient 
history, contact with the reference general practitioner and clinical records documenting 
the occurrence of the event/arrhythmia (De Luca et al., 2005, Izzo et al., 2013). Moreover, 
the patients were evaluated by a cardiac and carotid ultrasonography. Left ventricular 
mass was determined by using the formula developed by Devereux(Devereux et al., 1986) 
as recommend by American Society of Echocardiography (ASE)(Lang et al., 2005) and 
divided by the body surface area to calculate left ventricular mass index (LVMi, g/m2). 
B-mode ultrasonography of carotid arteries was performed in order to compute the 
maximum IMT (mm). Further details about the ECG recording, the cardioecographic and 
carotid ultrasonographic procedures can be found in a previous report(Melillo et al., 
2012). The current study was approved by the Ethics Committee of Federico II University 
Hospital Trust and the data were collected by the Department of Translational Medical 
science of the University of Naples Federico II in the framework of the Smart Health and 
Artificial intelligence for Risk Estimation (SHARE) project. 
2.3 ECG Holter database for Fall Risk 
2.3.1 Background and rationale 
ANS disturbance and cardiovascular disorders including carotid sinus hypersensitivity, 
serious arrhythmias, severe valvular heart disease, and coronary heart disease may be 
underestimated causes of falls(Isik et al., 2012). To investigate the relationship between 
abnormal HRV and fall risk, a database of ECG holter recorded in hypertensive patients 
with and without history of falls were collected ad hoc. 
2.3.2 Population 
The records have been collected among the hypertensive patients aged 55 or over, 
followed up by the outpatient hypertension centre of the University Hospital of Naples 
Federico II. The recordings were performed between January 2008 and December 2012. 
Clinical and demographic features of the included subjects are reported in Table 2.3. 
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Table 2.3 Clinical and demographic feature of the subjects included in the ECG Holter database for fall risk 
ID Sex Age Weight Height BSA10 BMI11 Smoker F hyp12 F stroke13 SP14 DP15 IMT16 LVMi17 EF18 Fall 
636 F 78 55 157 1.55 22.31 no yes no 170 60 2.3 136 64 yes 
782 M 76 70 160 1.76 27.34 no yes yes 145 75 3 146 60 no 
868 M 64 75 165 1.85 27.55 no no no 140 90 2.1 113 64 no 
2387 M 69 86 178 2.06 27.14 no yes no 143 75 1.9 128 64 yes 
2668 F 69 68 160 1.74 26.56 no no no 120 70 3.2 105 64 no 
2763 M 69 88 171 2.04 30.09 no yes no 120 70 1.7 133 62 no 
2841 F 77 84 165 1.96 30.85 no no no 170 85 2.4 120 68 yes 
2984 M 64 80 177 1.98 25.54 yes no no 110 60 3 121 57 yes 
2991 F 73 63 173 1.74 21.05 no yes no 140 70 2 137 60 no 
3340 M 65 107 170 2.25 37.02 no no no 130 85 2 146 64 no 
3495 F 84 75 160 1.83 29.30 no yes yes 170 80 0.95 154 59 no 
3534 M 77 84 173 2.01 28.07 no no yes 155 85 2 154 66 no 
3662 F 71 70 168 1.81 24.80 no no no 130 70 2 133 66 yes 
4609 M 77 89 163 2.01 33.50 no no no 125 80 1 118 69 no 
4668 F 69 80 159 1.88 31.64 no no no 142 82 2.2 133 66 no 
5016 F 66 64 156 1.67 26.30 no no no 130 75 2 129 60 no 
5222 M 65 100 173 2.19 33.41 no yes no 180 100 1.3 188 55 yes 
5400 M 73 80 178 1.99 25.25 no no no 135 80 2.4 103 67 no 
5431 F 84 48 160 1.46 18.75 no yes no 115 60 1.6 119 73 yes 
                                                 
10 Body surface area 
11 Body Mass index 
12 Family history of hypertension 
13 Family history of stroke 
14 Systolic arterial pressure 
15 Diastolic arterial pressure 
16 Intima media thickness 
17 Left ventricular mass index 
18 Ejection fraction 
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ID Sex Age Weight Height BSA10 BMI11 Smoker F hyp12 F stroke13 SP14 DP15 IMT16 LVMi17 EF18 Fall 
5451 F 81 76 158 1.83 30.44 no yes no 160 80 2 163 66 no 
5940 M 64 82 173 1.99 27.40 yes yes no 135 80 2 93 67 yes 
6106 M 73 92 173 2.10 30.74 no yes yes 155 85 3.6 139 52 no 
6215 M 75 84 170 1.99 29.07 no no no 140 85 2.2 172 44 yes 
6666 M 77 87 170 2.03 30.10 no yes yes 120 75 1.8 135 59 no 
7014 M 62 77 160 1.85 30.08 no no no 130 70 1.8 123 70 no 
7605 F 86 78 160 1.86 30.47 no yes no 145 55 2.2 122 59 no 
7633 F 68 54 152 1.51 23.37 no yes no 140 60 1.75 98 68 yes 
7842 M 63 89 160 1.99 34.77 no no no 125 75 3 127 68 yes 
7938 F 69 90 154 1.96 37.95 no yes no 110 65 1.5 124 64 no 
8500 F 63 75 168 1.87 26.57 no no no 120 80 1.1 99 72 no 
9205 M 65 72 167 1.83 25.82 no no no 130 85 2.3 106 68 no 
9278 F 64 98 165 2.12 36.00 no no yes 175 80 1.9 130 62 no 
9516 M 84 70 170 1.82 24.22 yes no no 164 54 3.5 194 63 no 
9629 M 85 70 170 1.82 24.22 no no no 147 65 1.8 129 65 yes 
9683 M 59 71 178 1.87 22.41 no yes no 150 90 1.4 144 71 yes 
9740 F 69 83 173 2.00 27.73 no no no 146 80 1.9 86 68 no 
10121 F 65 50 156 1.47 20.55 yes yes no 100 60 1 92 62 no 
10169 F 65 60 150 1.58 26.67 no no no 165 90 2 113 67 no 
10346 M 81 64 163 1.70 24.09 no yes yes 147 67 2.65 123 67 yes 
30061 M 71 80 160 1.89 31.25 no no yes 165 80 3.3 152 53 no 
30343 M 73 64 174 1.76 21.14 yes no no 125 75 1.2 119 67 no 
30415 M 74 82 173 1.99 27.40 no no no 145 80 2.4 104 65 no 
30472 F 80 80 165 1.91 29.38 no no no 177 75 2.5 164 56 no 
30521 F 72 55 160 1.56 21.48 yes yes no 160 80 3 99 65 no 
30671 M 68 62 165 1.69 22.77 yes no no 143 62 3.7 168 33 no 
30795 F 82 64 156 1.67 26.30 no no no 110 70 1.6 159 65 no 
30945 M 64 86 178 2.06 27.14 no no no 115 75 2.2 111 61 no 
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ID Sex Age Weight Height BSA10 BMI11 Smoker F hyp12 F stroke13 SP14 DP15 IMT16 LVMi17 EF18 Fall 
31663 F 68 95 162 2.07 36.20 no yes no 145 75 1.8 118 72 no 
31707 M 74 75 170 1.88 25.95 yes no no 145 85 2.2 144 62 no 
31769 M 86 73 168 1.85 25.86 yes no no 125 60 2.6 146 57 no 
31870 M 80 75 167 1.87 26.89 yes no no 105 65 2.3 117 52 no 
32713 M 74 83 170 1.98 28.72 no no no 145 85 1.5 120 48 no 
32750 F 75 68 156 1.72 27.94 yes no no 135 65 1.7 93 64 no 
32811 M 67 61 165 1.67 22.41 no no no 120 80 2.8 126 25 no 
32812 M 74 85 180 2.06 26.23 yes yes no 150 75 1.7 140 67 no 
33804 M 66 86 165 1.99 31.59 no no no 125 70 1.5 118 62 no 
33862 M 83 76 180 1.95 23.46 no no no 110 70 3.3 161 47 no 
34275 M 74 74 165 1.84 27.18 no no no 130 80 3.1 121 63 no 
34281 F 59 65 158 1.69 26.04 no no no 120 80 1.3 126 63 yes 
34538 M 65 93 175 2.13 30.37 no no no 120 80 1.7 112 65 no 
34647 M 91 85 172 2.02 28.73 no no no 130 60 4.6 180 59 yes 
35022 M 81 72 171 1.85 24.62 yes yes no 145 80 2.9 148 60 no 
35063 F 66 72 176 1.88 23.24 no yes no 130 85 2 117 66 no 
35325 M 66 86 167 2.00 30.84 yes yes no 140 60 2.8 142 62 no 
35693 M 70 98 176 2.19 31.64 no yes no 130 75 2.2 131 54 no 
35728 M 66 88 173 2.06 29.40 no no no 135 80 1.3 132 55 no 
36052 M 65 98 171 2.16 33.51 no no no 130 80 1.7 125 54 no 
36570 M 74 92 182 2.16 27.77 no no no 120 75 2.5 103 67 yes 
36886 M 73 68 167 1.78 24.38 no yes no 105 70 1.7 202 43 no 
36970 F 65 72 159 1.78 28.48 no yes no 150 90 3 105 67 no 
37293 M 78 68 162 1.75 25.91 no no no 130 70 2 131 67 no 
37314 M 69 65 175 1.78 21.22 no yes no 140 80 2.3 113 38 no 
37478 F 77 64 160 1.69 25.00 no yes no 110 60 1.5 146 70 no 
37511 M 81 68 166 1.77 24.68 no no no 130 85 2.3 141 33 no 
37591 F 80 58 153 1.57 24.78 n/a n/a n/a n/a n/a n/a n/a n/a no 
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ID Sex Age Weight Height BSA10 BMI11 Smoker F hyp12 F stroke13 SP14 DP15 IMT16 LVMi17 EF18 Fall 
38177 M 70 91 187 2.17 26.02 no no no 145 85 2.3 127 65 no 
38187 M 76 85 172 2.02 28.73 yes no no 120 70 3.8 184 33 no 
38668 M 70 76 172 1.91 25.69 no no no 120 80 3.1 140 54 no 
38719 F 71 74 172 1.88 25.01 no yes no 160 75 2.3 126 65 no 
38821 F 66 80 174 1.97 26.42 no no no 110 65 1.5 98 66 no 
39013 F 74 68 160 1.74 26.56 no yes no 160 65 4.6 115 70 yes 
39205 M 57 125 175 2.47 40.82 no no no 116 70 1.2 146 61 yes 
39666 M 64 112 181 2.37 34.19 no no no 145 80 1.9 114 63 yes 
40079 M 73 87 178 2.07 27.46 no yes no 175 65 1.8 233 53 no 
40121 F 65 67 159 1.72 26.50 no yes no 135 75 3.6 116 73 no 
40206 M 60 68 160 1.74 26.56 no no no 142 76 2.2 115 70 yes 
40578 M 67 72 171 1.85 24.62 yes yes no 120 85 n/a 144 61 no 
40972 M 68 87 170 2.03 30.10 no no no 155 80 1.6 136 64 yes 
41335 F 72 78 158 1.85 31.24 no yes no 190 80 4.2 154 72 no 
41647 M 74 78 166 1.90 28.31 no yes no 130 70 2.4 122 56 no 
41739 M 72 65 168 1.74 23.03 yes yes no 135 70 2.5 118 62 no 
42022 M 77 88 178 2.09 27.77 no no no 140 85 2.7 115 67 no 
42120 M 71 113 168 2.30 40.04 no no no 150 85 2.6 156 67 no 
42253 M 65 82 175 2.00 26.78 no yes no 120 80 2.5 154 56 no 
42494 F 72 70 165 1.79 25.71 no yes no 155 80 2.3 115 70 yes 
42617 M 61 74 171 1.87 25.31 no no no 130 80 1.25 139 61 yes 
43054 M 59 90 178 2.11 28.41 no no no 130 65 1.3 166 69 yes 
43375 M 76 91 185 2.16 26.59 no no no 110 65 2.8 121 45 yes 
43397 M 72 92 170 2.08 31.83 no no no 115 65 3.2 143 32 no 
43534 M 76 60 160 1.63 23.44 no no no 170 80 3.6 139 63 yes 
43582 M 81 93 170 2.10 32.18 yes no no 170 75 5 159 62 no 
43803 M 57 85 176 2.04 27.44 no no no 170 110 1.5 174 64 yes 
44058 F 64 83 155 1.89 34.55 yes no no 200 80 3.3 156 62 no 
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ID Sex Age Weight Height BSA10 BMI11 Smoker F hyp12 F stroke13 SP14 DP15 IMT16 LVMi17 EF18 Fall 
44089 F 67 65 159 1.69 25.71 yes no no 100 60 2.5 116 67 no 
44162 M 76 74 170 1.87 25.61 no yes no 115 70 1.9 113 61 no 
44310 M 59 68 164 1.76 25.28 yes no yes 100 60 1.4 98 69 no 
44349 F 74 91 162 2.02 34.67 no no no 140 80 2.3 101 72 no 
44372 F 77 54 160 1.55 21.09 no yes no 136 75 2 201 60 no 
44559 M 69 90 170 2.06 31.14 no no no 130 75 n/a n/a n/a yes 
44677 M 75 75 172 1.89 25.35 yes no no 122 74 3.3 121 68 no 
44729 M 84 83 181 2.04 25.34 yes no no 140 75 2.6 140 68 no 
44775 F 66 85 160 1.94 33.20 no no no 150 65 1.6 178 53 no 
44987 M 58 72 170 1.84 24.91 yes yes yes 150 75 3.8 142 56 yes 
45047 M 77 77 168 1.90 27.28 no no no 125 85 n/a n/a n/a no 
45065 M 79 81 172 1.97 27.38 yes no no 110 80 2.4 125 46 no 
45300 F 78 50 165 1.51 18.37 no no no 110 60 1.1 91 69 no 
45379 F 69 85 165 1.97 31.22 no no no 120 66 1.8 109 62 no 
45411 M 73 60 167 1.67 21.51 no no no 195 95 2.4 141 32 no 
45431 M 58 92 175 2.11 30.04 yes yes no 135 70 1.6 98 69 no 
45540 F 92 80 163 1.90 30.11 n/a n/a n/a 150 90 n/a n/a n/a yes 
45780 M 68 70 165 1.79 25.71 no no no 120 70 2.1 119 72 no 
45786 F 71 65 160 1.70 25.39 no no no 160 65 2.7 127 66 yes 
45854 F 69 60 167 1.67 21.51 no yes no 110 80 1.6 90 68 no 
45979 F 69 81 170 1.96 28.03 no yes yes 135 65 2.7 105 66 no 
46004 M 72 93 187 2.20 26.59 no no no 120 80 1.4 126 65 no 
46063 F 81 65 165 1.73 23.88 no no no 195 90 1.7 167 59 yes 
46087 M 75 75 176 1.91 24.21 yes no no 185 85 2.2 143 59 yes 
46123 M 70 82 178 2.01 25.88 no yes no 162 100 1.6 153 62 no 
46193 M 56 105 180 2.29 32.41 yes no no 140 80 4 123 66 no 
46198 M 84 72 170 1.84 24.91 no no no 120 70 2.6 147 51 no 
46354 F 68 55 165 1.59 20.20 no yes no 110 70 1.35 98 68 no 
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ID Sex Age Weight Height BSA10 BMI11 Smoker F hyp12 F stroke13 SP14 DP15 IMT16 LVMi17 EF18 Fall 
46480 F 76 70 160 1.76 27.34 no yes no 130 70 2.2 122 65 yes 
46527 M 59 89 175 2.08 29.06 no no no 145 85 1.15 122 67 yes 
46770 M 77 80 162 1.90 30.48 no yes yes 160 75 n/a 123 70 no 
46862 F 75 80 150 1.83 35.56 no no no 170 80 n/a 154 71 no 
46880 F 73 98 170 2.15 33.91 no yes no 155 78 2.9 129 65 no 
46971 M 74 74 172 1.88 25.01 no yes no 150 90 n/a n/a n/a no 
46978 F 70 93 165 2.06 34.16 no yes no 140 70 2.2 n/a n/a no 
46989 M 75 68 169 1.79 23.81 no yes no 160 90 2.7 107 70 no 
47017 F 69 76 158 1.83 30.44 no yes no 150 90 2.5 126 66 no 
47019 M 69 75 169 1.88 26.26 yes no no 150 86 2.2 n/a n/a no 
47086 M 65 70 163 1.78 26.35 yes yes no 150 80 n/a 108 72 no 
47173 F 64 63 162 1.68 24.01 yes n/a n/a 135 80 n/a 75 76 no 
47204 M 68 84 180 2.05 25.93 yes no no 155 85 2.6 121 33 no 
47296 M 65 84 168 1.98 29.76 yes yes no 150 90 2.8 167 38 no 
47347 M 77 80 169 1.94 28.01 yes no no 170 70 3 128 62 no 
47356 F 65 59 154 1.59 24.88 no no no 145 65 1.8 n/a n/a no 
47357 M 69 80 165 1.91 29.38 yes no no 150 90 2.5 n/a n/a no 
47448 M 63 72 168 1.83 25.51 no yes yes 135 85 1.4 n/a n/a no 
47457 M 66 100 170 2.17 34.60 no no no 135 75 1.6 166 47 no 
47476 M 65 83 165 1.95 30.49 yes no no 125 80 3.4 151 49 no 
47502 F 85 75 160 1.83 29.30 no no no 130 80 3.5 131 36 no 
47879 M 74 79 172 1.94 26.70 n/a n/a n/a 100 60 n/a 113 64 no 
47899 M 64 88 173 2.06 29.40 yes no yes 115 60 2.3 n/a n/a no 
47987 F 68 58 158 1.60 23.23 yes yes no 130 70 2.1 120 53 no 
48002 M 63 83 178 2.03 26.20 yes yes no 140 80 1.5 161 43 no 
48006 M 68 78 172 1.93 26.37 yes no no 135 85 1.6 127 52 no 
48040 M 79 70 170 1.82 24.22 no no no 135 80 2.8 n/a n/a no 
48128 F 66 64 160 1.69 25.00 no no no 140 60 3 96 69 no 
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ID Sex Age Weight Height BSA10 BMI11 Smoker F hyp12 F stroke13 SP14 DP15 IMT16 LVMi17 EF18 Fall 
48355 M 46 77 172 1.92 26.03 yes no no 145 75 3.3 108 68 no 
48366 M 78 72 174 1.87 23.78 no no no 155 75 2 127 66 no 
48396 M 77 82 169 1.96 28.71 no no yes 115 80 n/a 144 42 no 
48410 F 81 94 162 2.06 35.82 yes no no 130 80 3.2 102 63 no 
48526 M 69 69 165 1.78 25.34 yes no no 135 75 3 125 60 no 
48576 M 69 90 165 2.03 33.06 no no no 150 90 4 124 61 no 
48681 M 67 67 170 1.78 23.18 yes no no 120 80 n/a n/a n/a no 
48710 M 78 74 170 1.87 25.61 no no no 125 65 2.3 170 32 no 
50965 M 75 90 182 2.13 27.17 n/a n/a n/a 150 80 n/a 111 66 no 
51402 M 72 83 169 1.97 29.06 n/a n/a n/a 130 75 n/a 121 69 no 
100-1046 M 85 97 165 2.11 35.63 no no no 135 70 3 146 56 no 
100-1046 M 85 97 165 2.11 35.63 no no no 135 75 3 159 50 no 
100-1070 F 75 72 162 1.80 27.43 no no no 150 75 1.4 149 45 no 
100-200 M 83 75 170 1.88 25.95 no no no 145 70 3.3 129 58 no 
100-467 m 92 62 165 1.69 22.77 no no no 120 80 3 126 57 no 
100-959 F 66 89 167 2.03 31.91 no no no 120 70 1.9 175 28 no 
100-97 M 64 80 164 1.91 29.74 no no no 170 95 2.2 175 42 no 
47 
 
The following exclusion criteria have been adopted: 
 refusal of written informed consent; 
 severe ocular disease; 
 deafness in alone living subject; 
 chronic obstructive pulmonary disease, (pre)dementia, or other disease which may 
reduce life expectancy. 
The dataset consists of 168 hypertensive patients (including 60 female and 108 male, age 
72 ± 8 years). Among the study sample, 47 subjects experienced a fall during 3 months 
within the registration. 
2.3.3 Protocol and measurement system 
The ECG Holter was performed after a one-month antihypertensive therapy wash-out. On 
2 consecutive days, patients underwent a 24-hour ECG Holter recording. The recorders 
were applied between 9 and 11 AM on a working day, and the patients were asked to 
follow as closely as possible their usual daily activities during each monitoring session. 
They were asked to stay in bed from 11 PM to 7 AM, Moreover, the patients were 
evaluated by a cardiac and carotid ultrasonography, as described in section 2.2.3. The 
study was approved by the Ethics Committee of Federico II University Hospital Trust and 
the data were collected by the Department of Translational Medical science of the 
University of Naples Federico II in the framework of the Smart Health and Artificial 
intelligence for Risk Estimation (SHARE) project. 
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3 Data-mining 
Data mining can be defined as “the analysis of (often large) observational data sets to 
find unsuspected relationships and to summarize the data in novel ways that are both 
understandable and useful to the data owner”. It is an increasingly popular field including 
statistical, visualization, machine learning, and other data manipulation and knowledge 
extraction techniques aimed at gaining an insight into the relationships and patterns 
hidden in the data (Lavrač, 1999). The process of data mining includes the steps of data 
processing, feature extraction, feature selection, development of an algorithm, 
interpretation and evaluation. The data mining techniques could be distinguished in 
supervised (i.e. the algorithm infer a function from a labelled training data) and 
unsupervised (i.e. no a priori information is required and the technique is used to fit 
groups of instances characterized by homogeneous patterns). Formally, data represented 
in a table may be collected from measurements or acquired from experts. Rows in the 
table correspond to objects (training examples) to be analysed in terms of their properties 
(attributes) and the class (concept) to which they belong. In a medical setting, a concept 
of interest could be a set of patients with a certain disease or outcome. Supervised learning 
assumes that training examples are classified whereas unsupervised learning concerns the 
analysis of unclassified examples. Furthermore, the supervised learning techniques are 
usually distinguished in classification algorithms, which provide discrete output (e.g. 
binary class, such as health or disease condition; multiclass label for disease severity), 
and  regression algorithms, which provide a continuous output (e.g. the risk of developing 
a disease condition). The current chapter provides an overview of the data-mining 
techniques that were used in this thesis.  
3.1 Data-processing and feature extraction 
The RR time-series in the selected databases were analysed in order to extract HRV 
measures, which were used as input of classification algorithms. The length of the 
recordings was selected according to the aim: 
 nominal 24-hours (standard length for long-term HRV analysis)(Malik et al., 
1996) for CHF severity assessment; 
 5 minutes (standard length for short-term HRV analysis)(Malik et al., 1996) for 
fast assessment of risk of developing vascular events; 
 30 minutes (concurrent analysis of nominal 24-hour recordings in non-
overlapping 30 minute segments) (Hautala et al., 2010) for assessment of fall risk. 
All the extracted features are reported in Table 3.1. 
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Table 3.1 HRV measures computed in this thesis 
Abbreviation Description CHF CV Fall Ref. 
AVNN Average of all the NN intervals Yes Yes Yes (Malik et al., 1996) 
SDNN Standard deviation of all NN intervals  Yes Yes Yes (Malik et al., 1996) 
SDANN Standard deviation of the averages of NN intervals in all 5-minute segments Yes   (Malik et al., 1996) 
SDNN IDX Mean of the standard deviations of NN intervals in all 5-minute segments Yes   (Malik et al., 1996) 
RMSSD square root of the mean of the sum of the squares of differences between adjacent NN intervals Yes Yes Yes (Malik et al., 1996) 
NN50  number of differences between adjacent RR intervals that are longer than 50 ms  Yes Yes (Mietus et al., 2002) 
pNN50 percentage of differences between adjacent NN intervals that are longer than 50 ms Yes Yes Yes (Malik et al., 1996) 
pNN10 percentage of differences between adjacent NN intervals that are longer than 10 ms Yes   (Mietus et al., 2002) 
HRVTi  HRV triangular index  Yes Yes (Malik et al., 1996) 
TINN  triangular interpolation of RR interval histogram   Yes Yes (Malik et al., 1996) 
TOTPWR / TP Total spectral power up to 0.4 Hz Yes Yes Yes (Clifford and Tarassenko, 2005) 
ULF Spectral power between 0 and 0.003 Hz  Yes   (Clifford and Tarassenko, 2005) 
VLF Spectral power between 0.003 and 0.04 Hz  Yes Yes Yes (Clifford and Tarassenko, 2005) 
LF Spectral power between 0.04 and 0.15 Hz  Yes Yes Yes (Clifford and Tarassenko, 2005) 
HF Spectral power between 0.15 and 0.4 Hz  Yes Yes Yes (Clifford and Tarassenko, 2005) 
LF/HF Ratio of low to high frequency power  Yes Yes Yes (Clifford and Tarassenko, 2005) 
VLF%  relative power in very low frequency band (0 - 0.04 Hz)  Yes Yes (Malik et al., 1996) 
LF%  relative power in low frequency band (0.04 – 0.15 Hz)  Yes Yes (Malik et al., 1996) 
HF%  relative power in high frequency band (0.15– 0.4 Hz)  Yes Yes (Malik et al., 1996) 
VLFpeak  peak frequency of VLF band  Yes Yes (Malik et al., 1996) 
LFpeak peak frequency of LF band  Yes Yes (Malik et al., 1996) 
HFpeak  peak frequency of HF band  Yes Yes (Malik et al., 1996) 
HFnu  power in high frequency band (0.15– 0.4 Hz), expressed in normalized unit  Yes Yes (Malik et al., 1996) 
LFnu  power in low frequency band (0.04 – 0.15 Hz), expressed in normalized unit  Yes Yes (Malik et al., 1996) 
SD1  short-term variability in Poincaré Plot  Yes Yes (Brennan et al., 2001) 
SD2  long-term variability in Poincaré Plot  Yes Yes (Brennan et al., 2001) 
AppEn  Approximate Entropy  Yes Yes (Pincus, 1991) 
SampEn Sample Entropy  Yes Yes (Richman and Moorman, 2000) 
CD Correlation dimension  Yes Yes (Carvajal et al., 2005) 
Alpha1  short-term fluctuations in Detrended Fluctuation Analysis  Yes Yes (Penzel et al., 2003) 
Alpha2  long-term fluctuations in Detrended Fluctuation Analysis  Yes Yes (Penzel et al., 2003) 
DET  determinism  Yes Yes (Eckmann et al., 1987) 
REC  recurrence rate  Yes Yes (Eckmann et al., 1987) 
Lmean  mean length of lines in recurrence plot  Yes Yes (Eckmann et al., 1987) 
Lmax  maximal length of lines in recurrence plot  Yes Yes (Eckmann et al., 1987) 
DIV  Divergence  Yes Yes (Eckmann et al., 1987) 
ShanEn  Shannon Entropy  Yes Yes (Eckmann et al., 1987) 
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In the current section, the computation details for each feature are briefly reported, 
considering the following notation: RRj denotes the value of j'th RR interval and N is the 
total number of successive intervals. 
3.1.1 Time-domain HRV measures 
The most simple feature is the mean value of the RR interval time-series, referred as 
AVNN, and computed as in the following equation: 
(1) 𝐴𝑉𝑁𝑁 =
1
𝑁
∑ 𝑅𝑅𝑗
𝑁
𝑗=1 . 
The standard deviation of the RR intervals (SDNN) is computed as follows: 
(2) 𝑆𝐷𝑁𝑁 = √
1
𝑁−1
∑ (𝑅𝑅𝑗 − 𝐴𝑉𝑁𝑁)2
𝑁
𝑗=1 . 
The root mean square of successive differences (RMSSD) is given by: 
(3) 𝑅𝑀𝑆𝑆𝐷 = √
1
𝑁−1
∑ (𝑅𝑅𝑗+1 − 𝑅𝑅𝑗)2
𝑁
𝑗=1 . 
Another measure calculated from successive RR interval differences is the NN50 which 
is the number of successive intervals differing more than 50 ms and the corresponding 
relative amount pNN50: 
(4) 𝑝𝑁𝑁50 = √
1
𝑁−1
∑ 𝜗(|𝑅𝑅𝑗+1 − 𝑅𝑅𝑗| > 50 𝑚𝑠)
𝑁
𝑗=1  
where  ϑ() is the heaviside step function (i.e., the discontinuous function whose value is 
zero for negative argument and one for positive argument, formally 0)(  x  if 0x , 
otherwise 1)(  x ) and | | is the absolute value operator. 
Similarly, the pNN10 is computed as follows: 
(5) 𝑝𝑁𝑁10 = √
1
𝑁−1
∑ 𝜗(|𝑅𝑅𝑗+1 − 𝑅𝑅𝑗| > 10 𝑚𝑠)
𝑁
𝑗=1  
Moreover, in long-term analysis (segments longer than 5 minutes), two other parameters 
were computed: SDANN, i.e. the standard deviation of the averages of NN intervals in 
all 5-minute segments; SDNN IDX, i.e. the mean of the standard deviations of NN 
intervals in all 5-minute segments.  
In addition to the above statistical measures, there are some geometric measures that are 
calculated from the RR interval histogram. The HRV triangular index (HRVTi) is 
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obtained as the integral of the histogram (i.e. total number of RR intervals) divided by the 
height of the histogram which depends on the selected bin width. In order to obtain 
comparable results, a bin width of 1/128 seconds is recommended by International 
Guidelines(Malik et al., 1996). Another geometric measure is the TINN which is the 
baseline width of the RR histogram evaluated through triangular interpolation by least 
square methods(Malik et al., 1996). 
3.1.2 Frequency-domain HRV measures 
The frequency-domain HRV measures rely on the estimation of power spectral density 
(PSD), which could be computed with several methods. In this thesis Welch periodogram, 
AR method and Lomb-Scamble periodogram were adopted, for the following reason: 
 Welch’s periodgram has been previously adopted in the studies investigating 
discrimination ability of frequency-domain HRV measures between healthy and 
CHF patients(Asyali, 2003, Isler and Kuntalp, 2007, Melillo et al., 2011b), and, 
for that reason, it is considered as benchmark method. Moreover, the choice of 
parameters was performed according to these studies(Asyali, 2003, Melillo et al., 
2011b), that is, the NN interval was first interpolated with cubic spline 
interpolation at 4 Hz, then, the interpolated series was divided into overlapping 
segments of length 256 points (with a 50% overlap) and each segment was 
Hamming windowed.  
 AR model is the most widely used parametric method for HRV analysis, 
particularly with order model set to 16(Acharya et al., 2006).  
 Lomb-Scamble periodogram has been shown to provide a superior PSD estimate 
of RR series compared to FFT techniques, with reference to ectopy removal or 
replacement (Clifford and Tarassenko, 2005). This was due to the fact the Lomb-
Scamble periodgram did not require an evenly sampled time-series and 
consequently interpolation of the unevenly sampled RR times-series nor the 
replacement of missing beats.  
The generalized frequency bands in case of short-term HRV recordings are the very low 
frequency (VLF, 0-0.04 Hz), low frequency (LF, 0.04-0.15 Hz), and high frequency (HF, 
0.15-0.4 Hz). The frequency-domain measures extracted from the PSD estimate for each 
frequency band include absolute and relative powers of VLF, LF, and HF bands, LF and 
HF band powers in normalized units, the LF/HF power ratio, and peak frequencies for 
each band.(Malik et al., 1996) 
3.1.3 Nonlinear HRV measures 
3.1.3.1 Poincare Plot 
The two parameters of the Poincarè Plot SD1 and SD2 were computed according to the 
following formulae proposed by Brennan et al. (Brennan et al., 2001): 
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(6) 𝑆𝐷1 =
𝑆𝐷𝑆𝐷
√2
 
(7) 𝑆𝐷2 = √2𝑆𝐷𝑁𝑁2 −
1
2
𝑆𝐷𝑆𝐷2 
where SDSD is the standard deviation of the difference of RR interval time series. 
3.1.3.2 Approximate Entropy 
The AppEn was computed according to the algorithm here described.  
A series of vector of length m X1,X2, …, XN-m+1 is constructed from the RR intervals as 
follows:  
Xi,=[RRi, RRi+1 … RRi+m-1]. 
The distance ],[ ji XXd  between vectors iX  and jX  is defined as the maximum absolute 
difference between their respective scalar components. For each vector iX , the relative 
number of vectors jX  for which rXXd ji ],[ , )(rC
m
i  is computed where r is referred as 
a tolerance value (see the following equation).  
(8)  
j
mN
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Then, the following index )(r
m  is computing by taking natural logarithm of each 
)(rC mi  and averaging them over i. 
(9)  
)(ln
1
1
)(
1.
1
rC
mN
r mi
mN
i
m 



 
Finally, the approximate entropy is computed as:  
(10) 
)()(),,( 1 rrNrmApEn mm 
. 
Since several clinical studies(Pincus, 1991, Niskanen et al., 2004, Ho et al., 1997) have 
shown that either m=1 or 2 and r between 0.1 and 0.2 times the SDNN are suitable to 
provide valid value of AppEn, in the current thesis, m=1 and r=0.2 times the SDNN was 
adopted. 
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3.1.3.3 Sample Entropy 
SampEntropy computation is very similar to AppEn, with two important differences in its 
calculation: first, in the computation of )(rC mi  
the comparison of the vector X(i) with 
itself is included in the count for AppEn (self-match problem), while this comparison is 
excluded for SampEn; secondly, the logarithm is applied instead of subtraction in the final 
step. These changes aims to remove the bias in AppEn, as the count of the self-comparison 
in AppEn lower its value and the signals are interpreted as more regular than they are. 
Formally, the three steps of SampEn computation are described by the following 
equations: 
(11) ij
mN
rXXdofnumber
rC
jim
i 



1
}],[{
)(  
(12) 
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3.1.3.4 Correlation dimension 
Also, the CD is computed similarly to AppEn. The reconstruction of the attractor is the 
first step, that is, a series of vector of length m X1,X2, …, XN-m+1 is constructed from the 
RR intervals as follows:  
Xi,=[RRi, RRi+τ … RRi+ τ (m-1)] 
where τ is the time delay and m is the embedding dimension. The second step is the 
estimation of Euclidean distances between each couple of vectors: 
(14)  


m
k
jiji kXkXXXd
1
2))()((],[  
Then, the idea is to construct a function which estimates the probability that two arbitrary 
points on the orbit are close than r. So, the correlation integral function is determined by 
the following formula 
(15) ]),[(
)1(
1
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1
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where )1(  mNNm  and   is the Heaviside function.  
The correlation dimension is defined as the following limit value: 
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In practice, this limit value is approximated by the slope of the regression curve ( rlog ,
)(log rCm ).  
The appropriate value of τ could be chosen using the minimal mutual information 
technique(Fraser and Swinney, 1986, Fraser, 1989), while the value of m could be 
estimated with the methods proposed by Grossberger and Procaccia(Grassberger and 
Procaccia, 1983); in HRV analysis the values of 1 and 10 are widely used value for τ and 
m, respectively and for that reason they are adopted in the current thesis. 
3.1.3.5 Detrended fluctuation analysis 
The DFA consisted in the following steps: 
1) The average RR  of the RR interval series is calculated on all the N samples. The 
alternate component of RR interval series, which is defined as RR minus its 
average value RR , is integrated: 
(17) 



k
j
j NkRRRRky
1
,....,1),()(
. 
2) The integrated series is divided into non-overlapping segments of equal length n. 
A least square line is fitted within each segment, representing the local trends with 
a broken line. This broken line is referred as )(kyn , where n denotes the length of 
each segment. 
3) The integrated time series is detrended as follows: )()( kyky n . The root-mean-
square fluctuation of the detrended time series is computed according to the 
following formula: 
(18) 
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. 
4) The steps from 2 to 4 are repeated for n from 4 to 64. 
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Representing the function F(n) in a log-log diagram, two parameters are computed: short-
term fluctuations (Alpha1) as the slope of the regression line relating ))(log( nF  to )log(n  
with n within 4-16; long-term fluctuations (Alpha2) as the slope of the regression line 
relating ))(log( nF  to )log(n  with n within 16-64. 
3.1.3.6 Recurrence Plot 
The Recurrence Plot is designed according to the following steps.  
As in CD computation, vectors Xi= (RRi, RRi+τ, ..., RRi+(m-1) τ), with i=1,..., K, with K=[N-
(m-1)τ], where m is the embedding dimension and τ is the embedding lag, are defined. 
The Recurrence Plot is a K-dimensional matrix of dots, where a dot is placed if the 
Euclidean distance between Xi and Xj is lower than a threshold value r.  
Formally, the following steps are suggested for achieving the Recurrence Plot: 
1) A K-dimensional square matrix M1 is calculated computing the Euclidean 
distances of each vector Xi from all the others. 
2) A K-dimensional square matrix M2 is calculated as the matrix whose elements 
M2(i,j) are defined as: 
(19) 
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The Recurrence Plot is the representation of the matrix M2 in which a dot is associated to 
one value, that is, an image in which black pixels correspond to ones and white pixels to 
zeros. M1 is a symmetrical matrix as the distance between Xi and Xj is equal to the one 
between Xj and Xi and consequently, Recurrence Plot is a symmetric image along the 
diagonal.  
According to findings by Niskander et al. and Dabire et al.(Dabire et al., 1998, Niskanen 
et al., 2004), the following values of the parameters should be chosen:
SDRRmrm  ;1;10 .  
In the Recurrence Plot, lines are defined as series of diagonally adjacent black points with 
no white space. The length l of a line is the number of points which the line consists of. 
Moreover, some measures of Recurrence Plot are widely computed: recurrence rate 
(REC) defined in equation 20; maximal length of lines (lmax); mean length of lines (lmean); 
the determinism (DET) defined in equation 21; the Shannon Entropy (ShEn) defined in 
equation 22. 
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, with nl = percentage of Nl over all the number of 
lines. 
3.1.4 Commentary on the selected features 
In this thesis, the conventional time-domain and frequency domain HRV measures have 
been computed, since they are widely used in medical domain studies, and this enables 
the comparison with the results of previous studies (Casolo et al., 1995, Panina et al., 
1996, Sajadieh et al., 2003, Dekker et al., 2000, Binici et al., 2011, Arbolishvili et al., 
2006). Moreover, the nonlinear parameters which have been shown to change in 
pathophysiological cardiac condition(Acharya et al., 2004a, Acharya et al., 2004b, 
Acharya et al., 2006, Chua et al., 2008), have been selected: 
 Poincarè Plot parameters varied in case of premature ventricular complexes, atrial 
fibrillation, sick sinus rhythm  and ventricular fibrillation; 
 AppEn showed smaller values for cardiac abnormal cases, indicating smaller 
variability in the beat to beat, but, for sick sinus rhythm, it is higher compared to 
normal subjects; 
 SampEn has been introduced in order to remove the bias, which exists in the 
computation of AppEn(Melillo et al., 2014); 
 CD has been shown to decrease for different cardiac condition; 
 DFA slopes are decreased in very highly varying signals like premature 
ventricular complexes, left bundle branch block, atrial fibrillation and ventricular 
fibrillation; 
 RP plot showed, in normal cases, diagonal line and less squares indicating more 
variation indicating high variation in the heart rate. Abnormalities, like complete 
heart block and ischemic or dilated cardiomyopathy cases, show more squares in 
the RP plot indicating inherent periodicity and lower heart rate variation. 
3.2 Feature selection 
In this thesis, several features (measures) were extracted from ECG signals. Since the 
number of instances was relatively large compared to the number of available instances 
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for the training, feature selection techniques can be used to find the relevant features and 
discard the irrelevant or redundant ones in order to: 
 achieve a faster implementation of the algorithms (less time and memory are 
required to build a classifier if there are fewer features); 
 reduce or avoid the risk of over-fitting (models built on several features tend to be 
specific to the training set and, for that reason, less generalizable); 
 improve the performances (irrelevant features could degrade the performance of 
the algorithms); 
 improve the intelligibility of the classification models (it is easier to interpret the 
relations among a reduced number of features); 
 avoid the so-called curse of dimensionality, i.e. when the number of dimensions 
of the problem increases, the amount of instances required for an effective output 
(e.g. classification) grows exponentially. 
Formally, the problem of feature selection is defined as follows: given a set of d features, 
select a subset of size m that leads to the smallest classification error. The most 
straightforward approach to the feature selection problem would require: examining all 
(𝑑
𝑚
) possible subset of size m and selecting the subset with the smallest classification 
error. However, the number of possible subsets grows combinatorially, making this 
approach, which is referred as exhaustive search feature selection, impractical for even 
moderate values of m and d. Two other features selection techniques were adopted in this 
thesis: a chi-squared statistics(Liu and Setiono, 1995) and a correlation-based (Hall and 
Smith, 1997) feature selection methods. The first method ranked the features by 
computing the value of the chi-squared statistic of each feature with respect to the 
classification problem. The second method scores the worth of subsets of features by 
taking into account the usefulness of individual features for predicting the class along 
with the level of intercorrelation among them with the belief that good feature subsets 
include features highly correlated with the class, yet uncorrelated with each other.  
Moreover, in some circumstances, the feature importance measures based on Random 
Forests (RF) were computed(Breiman, 2001).  
3.3 Classification algorithms 
3.3.1 Classification and Regression Tree 
Classification and Regression Tree (CART), developed by Breiman et al. (Breiman, 
1984), has been used in several applications of pattern recognition especially for medical 
diagnosis (Esposito et al., 1997). The CART algorithm iteratively splits the data set, 
according to a criterion that maximizes the separation of the data, producing a tree-like 
decision structure (Breiman, 1984). The CART algorithms consists of two stages: tree 
growing and tree pruning (Breiman, 1984). In the former stage the tree grows by selecting 
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among all the possible splits, which generate the “purer” child nodes where the purest 
node is the one containing elements of only one class. The outcome of this step is further 
referred to as the Large-Tree. Among different functions that have been proposed for the 
measure of the impurity of each node t(Breiman, 1984) we adopted the Gini index 
criterion(Breiman, 1984), which for binary classification can be computed  as follows: 
(23) 
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where t is the considered node, i and j are the two class labels, ni and nj are the number of 
subject present at the node belonging to the class i or j, respectively, and n is the number 
of subject present at the node. 
In the latter stage, the Large Tree is pruned according to a minimal cost-complexity 
function, which relies on the tree size and the misclassification error. The 
misclassification error is estimated by the inner 10-fold-crossvalidation of the CART. The 
data set is randomly divided into 10 subsets. One of the subsets is used as independent 
testing dataset while the other 9 subsets are used as training dataset. The tree growing and 
pruning procedure is repeated 10 times, each time with one of the 10 different subsets 
used as a testing set. The misclassification error is calculated as the percentage of 
misclassified cases  averaged over all the 10 subsets.  
This procedure is repeated pruning the tree and for each sub-tree the cost complexity 
function is computed as a linear combination of the number of nodes and of the cross-
validated estimated of the misclassification error. The outcome of this stage is referred 
further to as the Best Sub-Tree, which is the sub-tree achieving the lowest value of the 
cost-complexity function. Further details about minimal cost-complexity pruning can be 
found in Breiman (Breiman, 1984). 
3.3.2 C4.5 
C4.5 is the landmark decision tree algorithm developed by Quinlan et al.(Quinlan, 1993). 
The feature of each node is selected in order to divide input samples effectively and 
information gain is used as a measure of effectiveness. After the induction of the decision 
tree, a pruning method was applied to reduce the tree's size and complexity.  
3.3.3 Random forest 
RF is a state-of-the-art classifier developed by Breiman(Breiman, 2001). It is composed 
of a number of decision trees that choose their splitting attributes from a random subset 
of k attributes at each internal node. The best split is taken among these randomly chosen 
attributes and the trees are built without pruning, as opposed to C4.5. One of the most 
relevant downsides of using RF, particularly in medical domain data-mining, is that its 
model is not easily understandable as a single tree.  
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3.3.4 Rotation forest 
Rotation forest (RTF) is an ensemble method capable of both classification and 
regression, depending on the base classifier (Kuncheva and Rodríguez, 2007). By default, 
rotation forest uses C4.5 decision trees as the base classifiers, although it is capable of 
using just about any classifier or combination of classifiers. The algorithm focuses on 
presenting transformed data to the classifier by using a projection filter such as principal 
component analysis (PCA), non-parametric discriminant analysis, random projections, 
and independent component analysis. The most successful projection filter is the PCA 
filter (Kuncheva and Rodríguez, 2007). The algorithm uses the boostrap method for 
creating the training set for each base classifier. The feature set is randomly split into M 
subsets and principal component analysis is applied to each subset. All of the eigenvectors 
are retained as the new features in order to preserve the variance in the data. The idea why 
these M data transformations are performed is to encourage simultaneously individual 
accuracy and overall diversity of classifiers within the ensemble, as this is the most 
important precondition for a successful ensemble (Breiman, 2001).  
3.3.5 Naïve Bayes classifier  
Naïve Bayes Classifier (NB) uses the naive Bayes formula to calculate the probability of 
each class given the values of all the attributes and assuming the conditional independence 
of the attributes(John and Langley, 1995). A new instance is classified into the class with 
maximum calculated probability.   
3.3.6 AdaBoost  
AdaBoost (AB) is a meta-learning algorithm which works by incrementally running 
classifiers on samples of data instances and combining them into an aggregate 
model.(Freund and Schapire, 1996) Each individual or weak classifier contributes to the 
aggregate model in proportion to its accuracy. After each iteration, data instances are 
reweighted based on incorrect aggregate classifications. This boosts the emphasis of 
misclassified instances, refining the construction of weak classifiers in future iterations. 
In the current study, C4.5 was adopted as weak classifier in the AB algorithm. 
3.3.7 Support Vector Machine  
Support Vector Machine (SVM) belong to a general field of kernel-based machine 
learning methods and are used to efficiently classify both linearly separable and linearly 
inseparable data.(Vapnik, 1998) When the data are not linearly separable, they could be 
transformed to a higher dimensional space by using a transformation function, which is 
the so-called kernel function. 
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3.3.8 Multilayer perceptron  
Multilayer perceptron (MLP) is one of the most popular neural network models due to its 
clear architecture and the simplicity of the algorithm(Bishop, 1995). It consists of a 
network of nodes (processing elements) arranged in layers. The principle of the network 
is that when data are presented at the input layer, the network nodes perform calculations 
in the successive layers until an output value is obtained at each of the output nodes. This 
output signal should be able to indicate the appropriate class for the input data. 
3.3.9 MultiBoost 
MultiBoost (MB) is regarded as an extension to AdaBoost that combines the AB 
algorithm with the wagging procedure, which is itself extension of the basic bagging 
method(Webb, 2000). Instead of K single classifiers used by the AB algorithm, MB 
constructs a number of sub-committees consisting of a number of trees. Each sub-
committee has its own specific iteration in which it terminates. Sub-committee is formed 
by AB using wagging instead of bootstrap. Wagging works by setting random weights of 
instances to those drawn from an approximation of the continuous Poisson distribution. 
After the weights are assigned, the vector of weights is always standardized to sum to N. 
All instances in the training set are used to train the base classifier using the designated 
weights. Using C4.5 as the base classifier for MB is straightforward, as C4.5 handles 
weights associated to instances. Wagging is shown to be particularly successful in 
reducing the variance error.  
3.3.10 RUSBoost and PCA 
RUSBoost (RB) is a hybrid approach recently proposed by Seiffert et al. (Seiffert et al., 
2010) to handle class imbalance. RB relies on the Random Under-Sampling technique 
and AB as boosting algorithm. CART was adopted as weak learner. RUS is one of the 
most common data sampling techniques, and simply removes examples from the majority 
class at random until a desired class distribution is achieved. However, since HRV 
features have been shown to be correlated, there is the risk that some of the computed 
features might be redundant and could worsen the classifier performance by increasing 
the running time and reducing its generalization ability. In order to find the optimal 
feature space, we adopted the PCA method (Kuncheva and Rodríguez, 2007) and we 
tested the proposed classifier with different number of dimensions. 
3.3.11 Synthetic minority over-sampling technique (SMOTE) 
SMOTE is an over-sampling approach in which the minority class is over-sampled by 
creating “synthetic” examples rather than by over-sampling with replacement(Chawla et 
al., 2002). The rare class was over-sampled by creating new synthetic rare class samples 
according to each rare class sample and its nearest neighbours.   
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3.4 Commentary on the selected data-mining methods 
The data mining methods employed in this thesis have been applied for intelligent data 
analysis in medicine. In particular, machine learning algorithms are usually classified in 
three group and at least one algorithm for each group has been selected: 
 Decision trees for inductive learning of symbolic rules; 
 Bayesian classifier and SVM for statistical or pattern-recognition methods;  
 MLP for artificial neural networks groups. 
Since in medical domain it is crucial that any computerised system is able to explain and 
justify its decisions, methods which provided intelligible models are preferred. For 
examples, decision tree classifier often give an appropriate explanation: induced decision 
trees are fairly easy to understand: positions of attributes in the tree, especially the top 
(most informative) ones, often directly correspond to domain expert’s knowledge(Lavrač, 
1999).For that reason, in all the application described CART or C4.5, that are the most 
used decision tree algorithm, were employed. However, even if these methods performed 
an inner feature selection, they showed weak performance when the number of features 
is higher than instances, the features are strongly correlated and the dataset is unbalanced, 
such as the databases employed in the current study. To deal with these issues, the author 
proposed novel strategies, based on a feature selection step and/or an oversampling 
method. This enabled to obtain intelligible models with comparable performance of other 
up-to-date classifiers (such as RF or MLP), which provide models difficult to interpret.   
The main problem with all the data-mining method is model shrinkage(Cooney et al., 
2009), that is, their predictive ability declines sharply once the model is applied to an 
external dataset, which limits their utility in clinical practice. Validating a classifier 
involves testing it on a set of subjects (the test set) that is independent of the training set. 
When the dataset is large, one can simply divide it into a training and test set (hold-out 
method). An effective and statistically justified validation method that can be used with 
smaller datasets is the cross-validation. The quality of the biomedical engineering 
literature on these topics is extremely varied: at the low end of the quality scale, one can 
find many papers that report no validation studies at all, but merely show that the classifier 
works well on the training set, which tells nothing about the predictive value of the 
classifier when faced with new data; many other paper lack sufficiently clear description 
of the validation methods to enable readers to judge the validity of the work(Foster et al., 
2014). 
The author of the present thesis proposed and strongly recommend a methodology to 
estimate the classification performances, based on a nest cross-validation approach. First 
of all, the hold-out approach should be adopted to split the dataset in a test set and a 
training set. The training set should be used for the classifier training, including the tuning 
of algorithm parameters. The optimal parameter and feature should be chosen according 
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to cross-validated estimation of the classifier performances. Finally, in order to increase 
the external validity of the develop model, data from multiple medical sites should be 
preferred, and this could be a further development of the clinical studies described in this 
thesis. 
3.5 Cloud-based architecture 
In order to provide the advanced functionality of ECG processing and the classification 
models, a web-based architecture was developed in the framework of the in the 
framework of the UE-funded research project “Smart health and artificial intel-ligence 
for Risk Estimation” (SHARE). The SHARE platform aims to integrate recording device 
and a Cloud infrastructure and consists of several basic services as shown in Figure 3.1.  
 
Figure 3.1 The system architecture of the SHARE platform 
In the architecture design, the following requirements were considered: 
 management of biomedical signal and data acquired in a highly seamless manner; 
 set up a scalable framework to support the processing of multiple data streams for 
concurrent application services. 
 persistent storage and exchange of data, their automatic analysis and availability 
everywhere to enable further decision making.  
It would provide a framework supporting data management, concurrent application 
execution, and data analysis. For that reason, a Cloud environment providing storage and 
Virtual Machine (VM)-based approach for computational process was adopted. Each 
component of the system was briefly described in this section. 
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The Bioharness™ (vers. 3 BH3, Zephyr Technology) is a state-of-art commercial 
wearable multi-sensing device, which enables long-term recordings of several biomedical 
signals and data. The BH3 is worn in epidermal contact with an elasticated strap at the 
chest (50 g, 50 mm width). The monitoring device (weight 35 g, 80x40x15mm) acts as a 
data logger or transmitter, has a memory of up to 480 hours and battery life of up to 24 
hours. Particularly, it can record one-lead ECG, breathing signal and respiration rate, 
posture, temperature, accelerometer signals along the 3 orthogonal axes. BH3 was chosen 
since it appeared a cheap and reliable device for health monitoring, useful both for 
cardiovascular issue and faller detection and since the manufacturer provided SDK. 
ShareAPP (referred as Share Cardio Health in Google Play) is an Android application, 
which has been developed ad hoc to provide a user interface for the patients, who could 
transmit the data acquired by BH3 in real time though a smartphone. The App was 
designed in order to minimize the user interaction. Moreover, it enables the physician to 
submit a daily questionnaire to the patients. 
ShareLogs is an ad hoc developed standalone application for Windows, which enables 
the upload of all the acquired signals by BH3 on the SHARE platform. It has been 
designed in order to follow the physician’s usual workflow: at each planned visit, the 
physician upload all the data stored on the BH3. This avoid the risk of losing the data that 
were not stored in real-time (e.g., because the mobile device was offline or out of 
Bluetooth coverage area or network problems). 
The Web Interface consists of a Content Management System (CMS) to show all the 
public information on the Project and a Restricted Area reserved to the system user, i.e. 
physician, researchers, patients. The CMS relies on Wordpress while the Restricted Area 
application was developed in ASP.NET (C#) by using Visual Studio 2013 and MySQL.  
The Web Services represent the software interface to store the data, acquired by BH3 and 
transmitted though the ad hoc applications. Moreover, they provided the most advanced 
functionality of the system, i.e. remote processing and data mining. 
The platform enabled the remote processing of ECG for HRV analysis, computing the 
feature described in the section 3.1. In particular, time-, frequency domain and nonlinear 
HRV measures are computed and examples are shown in  
Figure 3.2, Figure 3.3, and Figure 3.4. The ECG recording were analysed concurrently in 
segments of user-specified length. Finally, the SHARE platform provides an automatic 
assessment of cardiovascular risk, relying on data-mining approach applied to HRV 
measures. In particular, now a tree-based model is integrated in the web platform and an 
example of the results is shown in Figure 3.5. 
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Figure 3.2 An example of HRV analysis in the time-domain as provided by the SHARE platform 
 
 
Figure 3.3 An example of HRV analysis in the frequency-domain as provided by the SHARE platform 
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Figure 3.4 An example of nonlinear HRV analysis as provided by the SHARE platform 
 
Figure 3.5 An example of the results of the classification as provided by the SHARE platform 
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The most important advantages of the implemented system are the following: 
 it relies on a commercial multi-sensing wearable device for signal acquisition;  
 the most advanced functionalities i.e. ECG processing and automatic 
classification, were provided by the centralized structure of the system, and the 
users, i.e. physician, needs only to have a Web browser running in a personal 
computer and a network connection to access these services; 
 the technical programs can be updated and new tools can be easily added without 
interfering with the medical users. The addition or incorporation of a new 
technique in the GUI can be a quite simple task: a button is added which acts as a 
link to the function that runs under MATLAB and performs the corresponding 
processing. This fact makes the system into an open structure that can easily 
incorporate new tools as soon as they are developed, and therefore have an 
immediate presence in the support of clinical diagnosis; 
 the proposed architecture overcome the system based on the discontinued 
MATLAB WEB SERVER toolbox(Garcia et al., 2002), which has been 
discontinued by the manufactures; 
 most system proposed in previous studies focused on ECG storage and 
processing(Fortino et al., 2012, Hsieh and Hsu, 2012, Pandey et al., 2012), but 
they did not provide any automatic classification based on data-mining methods.  
Moreover, the system appeared to be well accepted by almost all the patients (95%) with 
a limited amount of data lost (<20%). Finally, the results of the clinical trials could 
provide the scientific evidences needed for the CE marking of the system as a medical 
device. 
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4 Results and discussion 
In this chapter the results of the data-mining methods applied to the database described 
in chapter 2 are shown and discussed. 
4.1 Automatic assessment of congestive heart failure severity 
The classification models described in this section aimed to discriminate between severe 
and mild CHF patients. The standard time- and frequency-domain HRV measures were 
extracted by 24h nominal ECG recordings from the Congestive Heart Failure RR Interval 
Database and the BIDMC Congestive Heart Failure Database. The patients with NYHA 
Class I and II were labelled as mild CHF, those with NYHA Class III and IV as severe 
CHF. CART algorithms with a feature selection algorithm (exhaustive search) was 
adopted in order to handle a small and unbalanced dataset. The performance of the 
proposed method was compared with other classifiers based on decision trees, i.e. C4.5 
(Quinlan, 1996) and RF (Breiman, 2001), enhanced with SMOTE, a standard data level 
based method to deal with imbalance. The performance of the models are evaluated by 
the most common measures for binary classification estimated by 10-fold-
crossvalidation. 
4.1.1 Results 
The performance of the proposed method (i.e. CART with exhaustive search feature 
selection approach) and benchmarks (i.e. C4.5 and RF, enhance with SMOTE) are 
reported in Table 4.1.  
The proposed method achieved higher values of accuracy than the benchmarks.  The 
higher performances were obtained by two different combinations of features: 
“TOTPWR, pNN10, pNN50, SDNN IDX” and “ULF, TOTPWR, pNN50”. 
Table 4.1 Classification performance measurement of the selected classifier estimated by 10-fold-cross-validation for 
classification of severe versus mild CHF patients 
Classifier  
Methods to handle 
class-imbalance  
TP 
# 
FN 
# 
TN 
# 
FP 
# 
F1 
% 
ACC 
% 
PRE 
% 
SEN 
% 
SPE 
% 
CART Here proposed  28 2 7 4 90.3 85.4 87.5 93.3 63.6 
RF SMOTE (k=5) 25 5 18 4 84.7 82.7 86.2 83.3 81.8 
C4.5 SMOTE (k=5) 25 5 19 3 86.2 84.6 89.3 83.3 86.4 
CART SMOTE (k=5) 22 8 17 5 77.2 75.0 81.5 73.3 77.3 
RF None 26 4 4 7 82.5 73.2 78.8 86.7 36.4 
C4.5 None 22 8 5 6 75.9 65.9 78.6 73.3 45.5 
CART None 29 0 0 11 84.5 73.2 73.2 100.0 0.0 
TP: the number of severe CHF patients correctly classified 
TN: the number of mild CHF patients correctly classified 
FP: the number of mild CHF patients incorrectly classified as severe CHF patients 
FN: the number of severe CHF patients incorrectly classified as mild CHF patients 
ACC: Accuracy; PRE: Precision; SEN: Sensitivity; SPE: Specificity 
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The selected Best Sub-trees are represented in Figure 4.1 and Figure 4.2. Each terminal 
node is the graphical representation of a set of “if … then” rules. For instance, the terminal 
node 2 in the Figure 4.1 can be read as: “if TOTPWR is lower than 11080.25 ms2 the 
subject is classified as a severe CHF patient”. 
 
Figure 4.1 The final model tree for the classification of severe versus mild CHF patients based on the combination of 
HRV features: TOTPWR, pNN50, pNN10, SDNN IDX 
In the model shown in Figure 4.1, the initial variable selected by CART (at node 1 split) 
was TOTPWR. The subjects whose TOTPWR is lower than 11080.25 ms2 were all 
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correctly classified as severe CHF patients. CART selected pNN50 for the second node 
split. In this node split, the subjects whose pNN50 were lower than 1.22% were classified 
as mild CHF patients. Otherwise, the following classification split was based on pNN10, 
that is, if it is lower than 36.093%, the subject was classified as severe CHF patient, 
otherwise a final classification split is based on SDNN IDX with a threshold of 100.910 
ms2. 
 
Figure 4.2 The final model tree (CART) for the classification of severe versus mild CHF patients based on the 
combination of HRV features: ULF, TOTPWR, pNN50 
 
70 
 
In the model shown in Figure 4.2, the initial variable selected by CART (at node 1 split) 
was ULF. The subjects whose ULF is higher than 21026.85 ms2 were correctly classified 
as mild CHF patients. CART selected TOTPWR for the second node split. In this node 
split, the subjects who’s TOTPWR were lower than 11080.25 ms2 were classified as 
severe CHF patients. A final classification split is based on pNN50, that is, if it is lower 
than 1.22%, the subject was classified as a mild CHF patient, otherwise as a severe CHF 
patient. 
4.1.2 Discussion 
The classifiers based on the combinations of standard long-term HRV measures 
“TOTPWR, pNN10, pNN50, SDNN IDX” and “ULF, TOTPWR, PNN50” enable 
distinguishing severe from mild CHF patients with an accuracy rate of 85.4%, a 
sensitivity rate of 93.3% and a specificity rate of 63.6% (10-fold-crossvalidation 
estimates). The existence of these two best combinations can be explained by the high 
correlation between HRV measures (Bigger et al., 1992, Malik et al., 1996).  
The selection of  pNN10 in the best combination would confirm its discrimination power 
proved by Mietus (Mietus et al., 2002). As concerns pNN50, Mietus et al. (Mietus et al., 
2002) showed that pNN50 failed to distinguish the LRPs and HRPs, while pNN50 is used 
in the Best Sub-Trees (see Figure 4.1 node 2 and Figure 4.2 node 4). This apparent 
inconsistency may be explained by considering that pNN50 could have a discriminative 
power only for the subgroups of patients which had high value of TOTPWR (TOTPWR 
> 11080.25 ms2), consistent with the absence of statically significant differences between 
the two patient groups. 
The sets of rules of both the models are clinically consistent, even if CART does not use 
any medical priori knowledge. In fact, the main clinical result of this research is that 
terminal node classifying as severe CHF are on the left, therefore revealing lower values 
of the splitting features for severe CHF patients (with the only exception of pNN50). This 
is coherent with the results showed by Casolo (Casolo et al., 1995), Panina (Panina et al., 
1996) and Arbolishvili (Arbolishvili et al., 2006). It should be emphasized that the 
findings of Casolo (Casolo et al., 1995), Panina (Panina et al., 1996) and Arbolishvili 
(Arbolishvili et al., 2006) were obtained adopting different methods for power spectral 
density estimation. Several methods were proposed in literature in order to estimate PSD 
of RR intervals (Malik et al., 1996, Rajendra Acharya et al., 2006). Particularly, many 
PSD estimators are based on the hypothesis that the signal under examination is uniformly 
sampled (Laguna et al., 1998). In contrast, the RR series is unevenly sampled and requires 
resampling before PSD estimation. In this study, Lomb-Scamble periodogram (Lomb, 
1976) was chosen as it estimates PSD of unevenly sampled signals without the requisite 
of resampling and its estimation has been proven to be more accurate than FFT-based 
method for RR data (Clifford and Tarassenko, 2005). 
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In relation to the methodology, the exhaustive research for feature selection improved the 
classification performance compared to CART model obtained using all the features. 
Moreover, as the study dataset is imbalanced, the performance of the proposed method 
are compared with SMOTE and with other two widely used decision tree methods. The 
proposed method achieved the highest performance in terms of accuracy rate and F1, 
which is one of the most suitable metrics for rare class problems (Shuli et al., 2009). 
Compared to a previous study, based on short-term HRV measures (Pecchia et al., 2010), 
the classifier proposed in the current studies achieved an higher accuracy and sensitivity 
(85.4% vs  79.3%, 93.3% vs 82.4%, respectively), even if with a lower specificity (75.0% 
vs 63.6%). This result leaded us to consider long-term HRV measures more effective for 
the individuation of severe CHF patients than short-term ones. 
As regards the other classifier proposed in literature for CHF assessment, Guidi (Guidi et 
al., 2012) compared different algorithms to automatically classify CHF patients in three 
groups (mild, moderate and severe) and achieved an accuracy of 86% (independent set 
estimate; sensitivity and sensibility are not reported) by using neural network. Guiqiu 
(Guiqiu et al., 2010) proposed a classifier based on support vector machine, which 
achieved an accuracy of 74% (10-fold-cross-validation estimate) in discriminating 
between mild CHF (NYHA I) and moderate/severe CHF patients (NYHA II and III). We 
underline that the classifier proposed by Guidi (Guidi et al., 2012) was based on 
anamnestic and instrumental data (not including HRV measures), and the one by Guiqiu 
(Guiqiu et al., 2010) was based on twelve parameters including LF/HF and other 
parameters from clinical tests (blood test, echocardiography test, electrocardiography test, 
chest radiography test, six minute walk distance test). For that reason some parameters 
needed by  the automatic classifier proposed by Guidi (Guidi et al., 2012) or Guiqui 
(Guiqiu et al., 2010) should be entered by physicians, while the adoption of only HRV 
measures, as in the current study, enables a completely automatic assessment. 
The current study had the following limitations related to the employed holter databases:  
a small and unbalanced dataset, the differences in the sampling frequency of ECG 
recordings and the different extraction procedures of NN intervals (for instance, some 
records were not manually reviewed and incorrect RR detections due to artifact may 
occur). The small sample size could result in biased cross-validated performance 
estimates, even if appropriate strategies (feature selection and tree pruning) have been 
adopted to avoid over-fitting and to increase the generalization ability. As regards the 
imbalanced dataset problem, a standard approach (oversampling) have been adopted as a 
benchmark to compare the proposed method. As regards the sampling frequency of ECG, 
it should be remembered that finite sampling frequency introduces an error in the RR 
interval measurement, as previously shown by Merri (Merri et al., 1990). However, a 
sampling rate of 128 Hz, which is the lowest sampling rate of the records used in this 
paper, has been found to be accurate enough to locate the R-peaks and hence compute 
HRV (Malik et al., 1996).  
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4.2 Automatic identification of hypertensive patients at high 
risk of vascular events 
The classification models described in this section aimed to identify hypertensive patients 
at higher risk to develop vascular events in the 12 months following the ECG recordings. 
Time-, frequency-domain and nonlinear HRV measures were extracted by 5-minute ECG 
segment randomly chosen from 24h nominal holter recordings. The patients who 
underwent a vascular event in the one year follow-up after ECG recording were labelled 
as high-risk, while the subject who were free of vascular event were labelled as low-risk. 
Several classification algorithms, with two feature selection algorithms, were adopted. In 
order to assess the generation ability of the models, the hold-out approach was adopted, 
i.e. the whole dataset was split into two subsets: training set (60% of instances) and test 
set (the remaining 40% of instances). The training set was used for feature selection and 
choice of the optimal parameters and SMOTE was adopted in order to handle a small and 
unbalanced dataset. The choice of the algorithm parameters and best subset of features 
was based on the performances (i.e. accuracy, then sensitivity and finally specificity) 
estimated by 10-fold cross-validation. The test set was adopted to evaluate the 
performance of the developed classifiers (with the features and parameters chosen on 
training set): ROC curves were constructed to compare the predictive value of each 
method for predicting vascular events and accuracy, sensitivity, specificity were 
computed according to standard formulae.  
4.2.1 Results 
The clinical characteristics of the study sample of patients were reported in Table 4.2. No 
statistical differences were detected between the two groups of patients in the 
demographic and clinical features.  
Among the 33 HRV features, the chi-squared statistics feature selection method identified 
as relevant the following features (reported in descending order of ranking): CD, SampEn, 
SD2, SDNN, LF, LFpeak, HF, HRVTi, TP, LF%, while the correlation-based algorithm 
selected the subset of the following features: HRVTi, LF, HF, LF%, LFpeak, SD2, SampEn, 
CD. Figure 4.3 showed the importance of each feature as computed by the RF algorithm. 
All the features identified by the feature selection methods were ranked among the ten 
most important features by RF, with the only exception of TP, which was ranked as 13rd.  
For each data-mining method, the optimal combination of parameters and the best subset 
of input features were selected by maximizing the accuracy estimated by 10-fold-
crossvalidation as shown in Table 4.3. AB classifiers were developed by varying the 
number of iteration from 20 to 400 and C4.5 trees (both as single classifier and as base 
classifier in AB) were developed by varying confidence factor for pruning from 0.05 to 
0.5, minimum number of instances per leaf from 5 to 20. MLP were trained by varying 
the learning rate from 0.3 to 0.9, the momentum from 0.2 to 1 and the number of epoch 
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form 100 to 2000. RF was constructed using an ensemble of random trees from 20 to 400 
with no depth limit and varying the number of randomly chosen features from log2(n)+1 
to n, where n is the number of feature. As regards SVM, we used radial basis function 
kernel, varying gamma from 10-5 to 10.  
Table 4.2 Clinical and demographic features of the subjects stratified by cardiovascular risk 
Clinical Features Low-risk subjects High-risk subjects 
p-value 
Age (years) 71.4±7 74.1±6.5 0.136 
Sex (female) 41 (33.6%) 8 (47.1%) 0.277 
Family history of hypertension 41 (33.6%) 7 (41.2%) 0.622 
Family history of stroke 10 (8.2%) 3 (17.6%) 0.236 
Smoking 35 (28.7%) 5 (29.4%) 0.983 
Diabetes 18 (14.8%) 3 (17.6%) 0.834 
Diastolic Blood Pressure (mmHg) 76.3±9.1 73.5±8.4 0.204 
Systolic Blood Pressure (mmHg) 136.6±19.5 141.7±23.5 0.326 
Total Cholesterol (mg/dl) 175.7±35.1 182.9±42.7 0.460 
Low Density Lipoprotein (mg/dl) 101±30.1 102±34.3 0.907 
High Density Lipoprotein (mg/dl) 52.4±13.1 53.3±15.3 0.813 
Body Mass Index (kg/m2) 27.6±3.9 27.9±4.9 0.793 
Body Surface Area (m2) 1.9±0.2 1.9±0.2 0.442 
Alpha-blockers 17 (13.9%) 3 (17.6%) 0.782 
Beta-blockers 50 (41%) 6 (35.3%) 0.487 
ACE inhibitor 37 (30.3%) 8 (47.1%) 0.247 
Dihydropyridine 27 (22.1%) 7 (41.2%) 0.131 
Intima Media Thickness (mm) 2.3±0.7 2.4±1.1 0.685 
Left Ventricular Mass index (g/m2) 130.1±26.1 140.2±25.1 0.135 
Ejection Fracion (%) 59.3±10.9 57.8±13 0.591 
Data are expressed as mean and standard deviation for continuous variables (e.g. age) and as count and percentage 
of patients per each group for categorical variables (e.g. gender). 
 
C4.5 and AB achieved the highest performances with chi squared feature selection 
algorithm, while MLP and NB with the correlation-based algorithm. SVM and RF 
performed well with all the features (i.e. without any feature selection step).  
The performance measurements estimated on the independent test set are reported in 
Table 4.4 for each classification algorithm based on HRV features. The RF outperformed 
the other data-mining methods by achieving the best value of performance measures, i.e., 
an accuracy of 85.7%, a sensitivity of 71.4%, and a specificity of 87.8%.  The prediction 
based on the echographic parameters, i.e., IMT and LVMi, resulted in a very low 
sensitivity rate (<45%), as shown in Table 4.4.  
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Figure 4.3 Feature importance computed by using Random Forest algorithm. 
Table 4.3 Performance measurement (10-fold-crossvalidation estimation) of the proposed algorithms based on HRV 
features 
Classifier Parameters 
Feature selection 
 (# features) 
AUC ACC SEN SPE 
AB NI: 220; CF 0.5; MI: 20 None (33) 94.5% 91.8% 93.2% 90.4% 
AB NI: 20; CF: 0.3; MI: 10 CFS (8) 92.2% 85.6% 86.3% 84.9% 
AB NI: 120; CF: 0.45; MI: 10  Χ2-FS(10) 94.7% 89.0% 90.4% 87.7% 
C4.5 CF: 0.3; MI: 5 None (33) 80.3% 76.7% 78.1% 75.3% 
C4.5 CF: 0.3; MI: 5 Correlation (8) 82.8% 80.8% 87.7% 74.0% 
C4.5 CF: 0.1; MI: 5  Χ2-FS (10) 83.0% 76.7% 76.7% 76.7% 
MLP LR 0.3; M 0.6; NE 200  None (33) 86.7% 82.9% 80.8% 84.9% 
MLP LR 0.6; M 0.4; NE 200 Correlation (8) 86.9% 78.1% 86.3% 69.9% 
MLP LR 0.3; M 0.2; NE 1800  Χ2-FS (10) 86.1% 78.8% 82.2% 75.3% 
NF - None (33) 72.4% 65.8% 76.7% 54.8% 
NF - Correlation (8) 80.1% 70.5% 78.1% 63.0% 
NF - Χ2-FS (10) 77.8% 71.9% 82.2% 61.6% 
RF NT 300 NF 5 None (33) 94.5% 88.4% 91.8% 84.9% 
RF NT 20 NF 5 Correlation (8) 92.3% 87.7% 90.4% 84.9% 
RF NT 400 NF 4 Χ2-FS (10) 93.2% 89.0% 93.2% 84.9% 
SVM G: 1.4 None (33) 93.1% 89.0% 86.3% 91.8% 
SVM G: 2.3 Correlation (8) 89.1% 81.5% 84.9% 78.1% 
SVM G: 1.6 Χ2-FS (10) 89.2% 80.8% 86.3% 75.3% 
CFS: correlation-based feature selection algorithm (a subset of 8 HRV features) 
Χ2-FS: chi-squared feature selection algorithm (a subset of 10 HRV features) 
NI: number of iteration; ML: minimum number of instances per leaf; CF: confidence factor for pruning; 
LR: learning rate; M: momentum; NE: number of epoch; 
NT: number of trees; NF: number of randomly chosen features; G: gamma; 
AUC: area under the curve; CI: confidence interval; ACC: accuracy; SEN: sensitivity; SPE: specificity; 
In bold: the best performances of each classifier. 
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The ROC curves (estimated on the independent test set) for predicting vascular events 
over twelve months with HRV or echographic parameters are compared in Figure 4.4. 
The HRV-based classifier showed higher AUC compared to echographic parameters. 
Among clinical parameters, the higher AUC was achieved by LVMi, followed by IMT. 
The other clinical available parameters (e.g. blood pressure, cholesterol) resulted in ROC 
with AUC lower than 0.5, i.e., worst performance than random choice, and for that reason, 
they are omitted. Among HRV-based classifier, SVM achieved the highest AUC, 
followed by RF. 
Since AB achieved satisfactory performances, it was interesting to observe the rules 
obtained from the decision tree with the highest weight, shown in Figure 4.5: 
 the subject was classified as low-risk if HRVTi>13.6; 
 a depression of HRVTi (<13.6) associated with a decreased SampEn (<0.997) or 
decreased LF% (<18.1%) leaded to high-risk classification; 
 otherwise, the subject was classified based on LF and CD, in particular, reduced 
CD (<3.43), although with LF > 0.011 s2, leaded to high-risk classification, 
otherwise, the subject was classified as low-risk. 
 
 
Figure 4.4 Receiver-operator characteristic curves for predicting vascular events by HRV-based classifiers and 
echographic parameters. 
The HRV-based classifiers are able to predict vascular events with higher sensitivity and specificity rate than 
echographic parameters. Sensitivity is determined from the proportion of patient developing a vascular event 
identified as high risk; specificity is determined from the proportion of patient free of vascular events identified as 
low risk. Solid lines represent classifier based on HRV features, dash-dot lines represent classifications based on 
echographic parameters. 
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Table 4.4 Performance measurements estimated on the test set (hold-out estimation) of the best classifiers based on 
HRV features and of classification based on echographic parameters 
Classifier / 
parameter 
Area under the curve Accuracy (95% CI) Sensitivity Specificity 
AB 81.9% 83.9%(76.9 – 86.6) 71.4% 85.7% 
C4.5 69.8% 75.0% (67.7 – 79.1) 57.1% 77.6% 
MLP 64.7% 76.8% (69.5 – 80.6) 42.9% 81.6% 
NF 74.9% 69.6% (62.4 – 74.4) 57.1% 71.4% 
RF 88.8% 85.7% (78.7 – 88.1) 71.4% 87.8% 
SVM 90.1% 83.9% (76.9 – 86.6) 71.4% 85.7% 
LVMi 63.5% 69.5% (69.9-73.0) 41.2% 73.9% 
IMT MAX 49.1% 61.9% (57.3-65.8) 40.0% 64.9% 
 
 
Figure 4.5 Decision tree for prediction of vascular events. The decision tree shows the set of rules adopted for 
classify high and low risk subjects: 
 
4.2.2 Discussions 
HRV features extracted from 5 minutes excerpts of 24 hours clinical ECG database of 
hypertensive patients were used to develop a computer-aided predictive tool that 
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improves risk stratification. Tree-based models applied on HRV features resulted 
effective in identifying high-risk patients among a population of hypertensive patients.  
Linear HRV features demonstrated prognostic value for vascular events (Sajadieh et al., 
2003, Dekker et al., 2000, Binici et al., 2011). Nevertheless, these traditional measures 
had only a partial predictive capability. The feature selection and ranking showed that 
nonlinear features, particularly CD, SampEn and SD2, increased the discrimination power 
when they were used in combination with the linear HRV features, such as HRVTi, LF, 
and HF. As a result, tree-based models showed to be effective at predicting vascular 
events among hypertensive. Nevertheless, the results clearly showed that the HRV-based 
classifiers had a better prognostic capacity compared with LVMi and IMT, which are 
considered as powerful predictors of vascular events (Lorenz et al., 2007, Nagai et al., 
2013, Schillaci et al., 2000).  
The sensitivity and specificity rates obtained in the current study were comparable with 
the performances achieved by Ebrahuimzaded et al.(Ebrahimzadeh et al., 2014) and by 
Song et al.(Song et al., 2014), who recently proposed HRV-based classifier for prediction 
of sudden cardiac death. However, in the present study none of the cardiovascular and 
cerebrovascular events occurred over the follow-up was fatal. Moreover, in the current 
study, we adopted a nested cross-validation approach: an inner 10-fold-crossvalidation 
loop was performed for model section (i.e., features selection and machine learning 
parameter optimization), while a hold-out test set was used to obtain almost unbiased 
estimates of the true classification performances. 
The sets of rules of the tree models presented were consistent with the findings of previous 
studies, even if no medical a priori knowledge was adopted in the data-mining methods. 
In fact, depressed HRV was showed to be associated with high cardiovascular risk in 
previous studies(Sajadieh et al., 2003, Dekker et al., 2000, Binici et al., 2011). Since HRV 
was proven to be the result of changes in heart rate caused by fluctuations in sympathetic 
and parasympathetic outflow, less compensatory change, as evaluated by depressed HRV, 
suggested a less adaptive ANS. One of the reasons could be that ANS resulted less 
sensitive for minor hemodynamic changes in some hypertensive patients, which could 
have been a direct cause of the vascular event registered in this study. Furthermore, a 
possible mechanism underlying our findings could be low-grade inflammation: it has 
been suggested that autonomic imbalance could activate inflammation by influencing the 
bone marrow and lymphoreticular system and increased inflammation is associated with 
higher risk of cardiovascular events(Sajadieh et al., 2004). Finally, another possible 
explanation for the association between HRV and vascular risk was that individuals with 
low HRV already suffered from subclinical or silent vascular disease, which, if not 
detected, resulted in cardiovascular events in the following months (Hillebrand et al., 
2013). 
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As regards the comparison of data-mining methods, RF showed extremely good 
performance in the current study when comparing several methods for diagnosis of 
congestive heart failure based on HRV features, confirming previous findings (Jovic and 
Bogunovic, 2011). Moreover, RF and SVM performed well without any feature selection, 
consistently with the capability of these algorithms to constitute embedded feature 
selection strategy, as demonstrated in previous studies (Saeys et al., 2008, Maldonado et 
al., 2011). 
The clinical feasibility and uptake of the developed tool are now tested in a prospective 
study in subjects aged 55 and over recruited by the Centre of Hypertension of the 
University Hospital of Naples. Moreover, since 5-minute HRV measurement is 
inexpensive, easy to assess, and non-invasive, future research will focus on the clinical 
applicability of the system as a screening tool in non-specialized ambulatories (e.g. at 
General Practitioners’), in order to identify high-risk patients to be shortlisted for more 
complex (and costly) investigations. Improved identification of individuals at risk for the 
development of vascular events may result in more targeted and adequate prevention 
strategies. 
4.3 Automatic identification of hypertensive patients with 
history of fall 
The classifier described in this section aimed to identify fallers among hypertensive 
patients (i.e. subject who referred at least one fall within three months from the ECG 
recordings). Time-, frequency-domain and nonlinear HRV measures were extracted by 
concurrent analysis of non-overlapping 30-minute ECG segments from 24h nominal 
holter recordings [8]. Several tree-based classification algorithms were adopted. In order 
to assess the performance of the classifiers, the 10-fold person-independent cross-
validation[10] was adopted. In the 10-fold person-independent cross-validation method, 
subjects are partitioned into two subsets in each round (totally 10 rounds): one with 90% 
subjects for training and the other with 10% subjects for testing. This technique 
guarantees that each subject appears only once in the testing set and 9 times in the training 
set and any subject used for testing does not appear in the training set because the partition 
is based on the subjects rather than the individual excerpts. Since a subject-based 
classification was required, for each subject, the proportion of excerpts classified as 
fallers was computed and considered as an estimate of the probability that the subject 
belongs to fallers. A subject-based ROC curve analysis was performed: for all the cut-
points, true and false positive rates were calculated and we selected as best cut-point the 
one that maximizes the true positive rate, provided a false positive rate lower than 20%.  
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4.3.1 Results 
No significant differences in age and gender distribution were detected between the 
subjects with and without an history of fall (at least one fall within 3 months from the 
recordings). 
Several classification algorithms have been trained and tested with the parameter values 
here reported:  
 RF was constructed using an ensemble of 100 random trees with no limit to tree 
depth; 
 RTF was constructed of an ensemble of 10 C4.5 trees using PCA filter (all 
dimensions retained);  
 AB was used in combination with C4.5 classifier, the number of iterations was 
varied between 10 and 200 with steps of 50 iterations;  C4.5 decision tree was 
tested with a variable minimal number of observations in each leaf (2, 5, 10, 20). 
Confidence factor for pruning was set to default of 0.25;  
 MB was used in combination with C4.5 classifier, the number of iterations was 
varied between 10 and 200 with steps of 50 iterations, C4.5 decision tree was 
tested with a variable minimal number of observations in each leaf (2, 5, 10, 20). 
Confidence factor for pruning was set to default of 0.25. The number of sub-
committees was set to 30% of the number of iterations (classifiers), as default.  
 RB was evaluated with PCA dimension varying between 2 and 20. The number 
of iterations was varied from 20 to 500 with steps of 20 iterations, and CART was 
tested with a variable minimal number of observations in each leaf (5, 25, 50 and 
RB’ default) and of misclassification cost ratio (from 1 to 20). Post-sampling 
50:50 class distribution was adopted.  
The ROC curves of the best classifier for each algorithm are shown in Figure 4.6 and the 
related performances for the selected cut-points (higher true positive rate, provided a false 
positive rate lower than 20%) are reported in Table 4.5.  
Table 4.5 Best Performance of the Adopted Classification Methods for identification of subjects with history of falls 
Classifier 
AUC 
% 
ACC 
% 
SEN 
% 
SPE 
% 
PPV 
% 
NPV 
% 
OR 
(95% CI, p-value) 
RF 46.3 67.3 21.3 85.1 35.7 73.6 1.5 (0.6-3.6, 0.32) 
RTF 51.5 67.9 21.3 86.0 37.0 73.8 1.6 (0.7-3.9, 0.25) 
AB 51.7 68.5 25.5 85.1 40.0 74.6 2.0 (0.9-4.5, 0.10) 
MB 54.1 63.7 17.0 81.8 26.7 71.7 0.9 (0.4-2.2, 0.86) 
RB 63.9 69.0 40.4 80.2 44.2 77.6 2.7 (1.3-5.7, 0.007) 
RB & PCA 67.6 72.0 51.1 80.2 50.0 80.1 4.2 (2.0-8.7, <0.001) 
AUC: area under the curve; ACC: accuracy; SEN: sensitivity; SPE: specificity; PPN: positive predictive value; 
NPV: negative predictive value; OD: odds ratio; CI: confidence interval 
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Figure 4.6 Comparison of the ROC curves of automatic classifier for identification of subjects with history of falls 
 
The algorithms based on the boosting approach appeared to be superior to those based on 
bagging and the method based on RB achieved better performances, in terms of accuracy, 
sensitivity, positive and negative predictive value, compared to the other classifiers. 
These results were achieved with the following values of the parameters: 11 PCA 
dimensions, 180 iterations, learning rate of 0.7, misclassification cost ratio of 5, and 5 
minimal observations in leaves. In particular, Random Under-Sampling improved the 
performance of AB algorithm, increasing the AUC from 51.7% to 63.9% and the 
sensitivity rate from 25.5% to 40.4% without relevant decrease in specificity rate. Using 
PCA resulted in a further improvement of the RB performance, by increasing sensitivity 
rate from 40.4% to 51.1% and AUC from 63.9% to 67.6% (with an unchanged specificity 
rate of 80.2%).  
4.3.2 Discussions 
An automatic classifier based on HRV analysis was developed in order to identify subject 
with a history of fall among hypertensive cardiovascular patients. To the best of authors’ 
knowledge, only another study (Isik et al., 2012) investigated the discrimination power 
of HRV features for fallers’ identification using 24h ECG, but it was a retrospective study 
and did not proposed an automatic classifier method. Moreover, in that study (Isik et al., 
2012), the authors adopted only standard linear HRV methods, such as SDNN, RMSSD, 
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pNN50, and observed no significant differences in these measures between fallers and 
non-fallers. The statistical analysis on HRV linear and nonlinear measures of the current 
dataset showed that frequency and nonlinear measures significantly differed between 
fallers and non-fallers, suggesting that the choice of only standard linear methods, as done 
in Isik et al. (Isik et al., 2012) could not be satisfactory. 
The best performance presented in this paper was achieved by a hybrid data-mining 
algorithm, RB, integrated with feature extraction based on PCA. This classifier achieved 
a relatively high specificity and accuracy (80% and 72% respectively), but low sensitivity 
(51%). Particularly, the sensitivity rate achieved is consistent with the findings of 
(Rubenstein, 2006) which highlighted that at least the 42% of falls are due to transient 
problems, which are related to ANS and cardiovascular system states. Since a limited part 
of falls are directly caused by cardiovascular system (i.e. syncope), the results presented 
in the current paper suggested for the first time that ANS / cardiovascular system 
dysfunctions may be responsible for a temporary reduced capability to react to extrinsic 
risk factors (i.e. reduced reflex velocity) avoiding falls. Moreover, for the first time this 
study proved that these dysfunctions are detectable with HRV monitoring. Moreover, the 
low rate of false positives (1 – specificity, 19.9%) suggested that this approach based on 
HRV analysis could be successfully used in clinical settings, eventually in combination 
with other approaches. 
Several fall risk assessment tools in elderly population have been proposed in literature 
and showed a wide variability in the reported diagnostic accuracy: sensitivity varied from 
43% to 100% and specificity varied from 38% to 96% (Perell et al., 2001). The method 
proposed in the current study achieved higher performance than several test for predicting 
falls: Fig. 2 shows the comparison between ROC curves of the proposed method and those 
of several functional mobility tests for predicting falls in community-dwelling older 
people(Tiedemann et al., 2008). The proposed method outperformed all the functional 
tests, which had relative risk (RR) ranging from 1.3 to 2.3 and sensitivity and specificity 
scores ranging from 11% to 78%, and 28% to 93%, respectively. More recently, a Stroop 
Stepping Test (SST) using low-cost computer gaming technology has been proposed to 
discriminate between older fallers and non-fallers, but the authors provided only the odds 
ratio (1.7) (Schoene et al., 2014), which is lower than the one here proposed (DOR=4.2, 
CI95% 2.0-8.7, p-value <0.001). Finally, the method proposed in the present paper is 
clinically feasible, since it only requires a 24h ECG recording, which is often performed 
in cardiovascular patients also though wearable devices(Baig et al., 2013). For instance, 
the method proposed do not require the use of other technologies as wearable 
accelerometers or pressure matrices, which are not used in everyday clinical practices, 
not having direct benefits for cardiovascular outpatients. For that reason, the method 
proposed could be used widely in outpatient settings to identify high-risk patients who 
need further assessment and could benefit from fall prevention programs or fall detection 
systems (Mirmahboub et al., 2013, Yun et al., 2014, Evans et al., 2014).  
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Figure 4.7 Comparison of performance of the proposed method with several functional mobility tests proposed in 
literature for faller identification (STS: Sit-to-stand once, STS-5: Sit-to-stand five times, HT: Half-turn-test steps, AS: 
Alternate-step test, SMW: Six-metre walk, SA: Stair ascent, SD: Stair descent) 
Regarding the classification data-mining methods, we adopted up-to-date ensemble 
algorithms based on bagging (i.e. RF, RTF) and boosting (i.e. AB, MB, RB), showing 
that the latter appeared to be superior to the former, maybe because RF performance could 
be more affected by the dependency structure of the data (Adler et al., 2011). Moreover, 
as recently proposed by Seiffert et al. (Seiffert et al., 2010), when the dataset is 
imbalanced, as in the current study, the performance of boosting algorithm could be 
improved by integrating it with a data sampling technique. Finally, since previous studies 
showed the importance of feature selection for learning from small and imbalanced 
datasets (Zheng et al., 2004), we proposed to integrate RB with a feature extraction 
method based on PCA and observed that using PCA resulted in higher performances 
compared to RB and also to bagging classifier adopting PCA filter. 
This study had some limits. The dataset used was not specifically designed to study falls. 
Therefore, important information, such as the exposure to other independent intrinsic risk 
factors for falls could not be accessed or used to verify independently the results. 
Moreover, the fall recordings were based on patient self-reports, which are considered 
not every time reliable as some non-harmful falls can be forgotten and not reported. 
Therefore, the number of falls could have been underestimated. In addition, the results of 
the classifiers could be difficult to interpret as the methods employed mixed and masked 
those HRV features that have an accepted clinical meaning. However, with respect to 
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maximum achieved accuracy, the opaque models obtained from automatic classifiers 
have an advantage over those with clear interpretation. It should be noted that automatic 
systems in this field are sufficient to provide early warning signs before adequate medical 
assessment can be performed. Finally, the current findings have been obtained in a 
population of cardiac patients, in which HRV is already known to be depressed compared 
to healthy people. This suggests that depressed HRV could be a more relevant risk factor 
for falls in people free of cardiovascular disease. 
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5 Conclusion  
 
The aim of this thesis was to research and develop automatic methods based on ANS 
assessment for evaluation of risk in cardiac patients (i.e., affected by CHF or 
hypertension). HRV analysis have been adopted as non-invasive marker of the ANS 
status and several data-mining methods have been combined to achieve the following 
goals: 
 Automatic assessment of disease severity in CHF patients; 
 Automatic identification of hypertensive patients at higher risk of developing 
vascular events; 
 Automatic identification of hypertensive patients with a history of falls. 
Automatic assessment of disease severity in CHF patients: previous studies focused on 
discrimination of CHF from healthy subjects, and some of the proposed methods relied 
on HRV measures. Few studies focused on disease severity and they adopted parameters 
that should be manually entered by the physician. For the first time, a completely 
automatic method, based on long-term HRV measures (i.e., extracted from nominal 24-h 
ECG recordings), was proposed in order to automatically assess the CHF severity (mild 
versus severe CHF). It has been developed by using public databases, freely available 
from the physionet.org website. Since the dataset is unbalanced, an approach based on 
feature selection and tree-based classifier was proposed and compared to standard 
methods to handle the imbalance problem.  
Automatic identification of hypertensive patients at high risk of vascular events: previous 
clinical studies showed that depressed HRV was associated with cardiovascular risk and 
a few recent studies focused on short-term prediction of sudden cardiac death or other 
cardiovascular fatal events. For the first time, a completely automatic system was 
proposed in order to identify hypertensive patients at higher risk to develop vascular 
events (e.g. stroke, myocardial infarction, syncope) in the 12 months following the 
recordings. It was based on linear and nonlinear HRV analysis of a 5-minute ECG 
segment. A rigorous validation method, based on a crossvalidation loop nested in a hold-
out splitting, was proposed to compare the performance of several data-mining 
algorithms, based on different approaches. The algorithms were trained on a database 
developed ad hoc, which is now available in the PhysioNetWorks area of the 
physionet.org website. The clinical feasibility and uptake of the developed tool are now 
tested in a prospective study in subjects aged 55 and over recruited by the Centre of 
Hypertension of the University Hospital of Naples Federico II. Moreover, since 5-minute 
HRV measurement is inexpensive, easy to assess, and non-invasive, future research will 
focus on the clinical applicability of the system as a screening tool in non-specialized 
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ambulatories (e.g. at General Practitioners’), in order to identify high-risk patients to be 
shortlisted for more complex (and costly) investigations. Improved identification of 
individuals at risk for the development of vascular events may result in more targeted and 
adequate prevention strategies. 
Automatic identification of hypertensive patients with history of fall: ANS disturbance 
and cardiovascular disorders may be underestimated causes of falls. For that reason, it 
was explored whether an automatic identification of fallers among hypertensive patients 
based on HRV was feasible. The proposed method outperformed several functional tests 
which were proposed in literature for faller identification. Moreover, it does not require 
the use of other technologies as wearable accelerometers or pressure matrices, which are 
not used in everyday clinical practices, not having direct benefits for cardiovascular 
outpatients. For that reason, the method proposed could be used widely in outpatient 
settings to identify high-risk patients who need further assessment and could benefit from 
fall prevention programs or fall detection systems. 
The results obtained in this thesis could have implications both in clinical practice and in 
clinical research. The system have been designed and developed in order to be clinically 
feasible. In particular, HRV analysis and the automatic system for identification of high-
risk patients are integrated in a web-based platform, developed in the framework of the 
Smart Health and Artificial Intelligence for Risk estimation (SHARE) project. The 
platform, now integrated in an open and interoperable cloud computing platform for 
health and eGovernement (PRISMA), included a standalone software (for Windows 
operative system) and an Android application to acquire signals from wearable devices.  
Finally,  the findings obtained by the data-mining methods (which did not use any a priori 
knowledge) reinforce the previous clinical observation that depressed HRV is a marker 
of cardiovascular risk and, for the first time, showed that it could be also an interesting 
parameter to be investigated in fall identification and prevention research. 
The main limitation of the presented studies is the relatively small sample size of the 
datasets. This issue could be addressed in the next future by increasing the number of 
enrolled subjects by Centre of Hypertension of the University Hospital of Naples Federico 
II. This would make the present findings clinically more relevant. Moreover, the dataset 
used in the fall identification issue was not specifically designed to study falls. Therefore, 
important information, such as the exposure to other independent intrinsic risk factors for 
falls could not be accessed or used to verify independently the results. Moreover, the fall 
recordings were based on patient self-reports, which are considered not every time 
reliable as some non-harmful falls can be forgotten and not reported. Therefore, the 
number of falls could have been underestimated.  
Further developments of the current thesis could be the adoption of new HRV measures 
(e.g. point process time-frequency analysis), strong risk markers extracted from ECG (e.g. 
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Heart Rate Turbulence or T wave alterations), and other non-invasive measures obtained 
by wearable sensors (e.g accelerometric signals, breath rate).  
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List of abbreviations  
The following table describes the meanings of several abbreviations and acronyms used 
throughout the thesis. The abbreviation adopted in each table are reported in the footnotes. 
The abbreviation for HRV measures are reported in Table 3.1 
 
Abbreviation Meaning 
ANS Autonomic Nervous System  
HRV Heart Rate Variability  
PSD Power Spectral Density  
FFT  Fast Fourier Transform  
CHF Congestive Heart Failure  
ECG electrocardiographic signals  
STS-5 sit-to-stand test with five repetitions  
STS-1 single sit-to-stand task  
AST alternate-step test  
SMWT six-metre-walk test  
AR Auto-Regressive  
RF  Random Forests  
RTF Rotation forest  
CART Classification and Regression Tree  
PCA principal component analysis  
NB Naïve Bayes Classifier  
AB AdaBoost  
SVM Support Vector Machine  
MLP Multilayer perceptron  
MB MultiBoost  
RB RUSBoost  
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